rfhg_50443.1

Basic information about the TSS

---

TSS ID: rfhg_50443.1 Species: human Chr: chr3		Start: 133573771 End: 133573779 Strand: +
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AF103803:-41 GeneID: 55573 HGNC/MGI_ID: HGNC:26928 UniProt_ID: Nearer transcript ids and distances: ENST00000264993.8:-85 NM_001282762.2:-85 NM_017548.5:-85 NM_001134422.2:-85 ENST00000431519.6:197 BC007338:197 KJ905498:265 ENST00000503932.5:301 view more...

Gene_name: CDV3 homolog Gene_symbol: CDV3 Gene_synonyms: H41 Gene_source: HGNC:26928

TATA-Box annotation

---

Distance to TSS:	89
Nearest PromoterID:	NM_001282762
Entrez ID:	55573
Nearest Unigene:	Hs.518265
Nearest Refseq:	NM_017548
Nearest Ensembl:	ENSG00000091527
Gene Name:	CDV3 homolog
Gene Alias:	H41
Gene Type:	protein-coding
CpG%:	0.125000
GC%:	0.555556
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CDV3 p2@CDV3 p3@CDV3 p4@CDV3 p5@CDV3 p7@CDV3 p8@CDV3 p9@CDV3 p10@CDV3
Sample		p1@CDV3	p2@CDV3	p3@CDV3	p4@CDV3	p5@CDV3	p7@CDV3	p8@CDV3	p9@CDV3	p10@CDV3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	64.87	27.66	27.47	10.32	5.84	4.87	1.36	1.56	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	63.73	29.54	29.74	11.13	7.89	3.64	0.61	1.01	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	68.48	32.41	28.94	14.08	7.33	3.09	1.16	1.35	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	65.28	21.21	23.08	13.51	6.65	3.74	0.21	0.42	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	74.46	30.37	30.15	14.40	13.27	2.92	0.22	1.35	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	64.73	30.82	24.81	13.95	9.69	4.07	0.39	1.36	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	72.56	40.74	28.54	18.30	11.55	6.75	1.96	1.31	2.18
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	82.60	30.76	28.58	21.32	7.02	1.45	0.97	0.48	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	72.45	32.06	23.51	18.17	11.11	3.21	0.21	1.07	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	73.03	29.56	25.50	19.13	5.80	3.48	1.16	2.90	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	60.64	28.30	25.47	21.02	5.66	3.23	2.02	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	61.39	32.93	26.83	18.29	7.72	2.44	0.81	1.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	64.15	11.77	14.02	7.09	9.19	2.74	2.42	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	46.91	11.13	12.63	3.76	8.27	3.16	2.26	0.90	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	52.47	9.22	13.83	6.37	9.88	2.42	2.42	0.88	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	48.79	10.56	14.84	5.03	7.04	1.76	2.01	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	51.76	8.95	14.41	8.08	8.52	3.06	3.28	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	57.79	11.39	12.23	6.33	7.17	8.44	0.84	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	52.25	10.13	14.93	5.33	9.06	1.60	1.60	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	59.27	11.13	17.30	6.62	11.28	3.61	1.81	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	58.14	13.77	17.78	6.15	11.23	3.74	2.00	0.53	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	57.48	14.33	21.23	5.18	10.70	3.45	2.93	0.86	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	57.65	11.63	20.81	7.37	6.98	2.84	2.84	0.65	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	61.88	11.41	21.84	3.64	9.46	3.40	2.18	0.24	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	73.79	10.06	22.96	7.74	12.38	3.35	1.81	0.52	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	70.90	13.61	21.84	8.23	13.29	6.33	3.17	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	71.98	15.93	25.28	8.24	7.69	3.30	4.40	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	70.25	16.97	29.00	9.67	12.26	4.48	0.94	1.41	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	62.03	13.41	22.13	9.53	12.44	3.55	1.94	1.29	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	62.25	14.12	25.34	8.69	12.67	4.89	2.71	0.90	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	62.59	11.51	20.93	7.96	8.58	4.81	2.09	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	61.55	13.29	27.35	6.25	9.38	5.86	3.71	0.59	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	65.84	18.36	23.85	6.54	10.76	6.75	3.38	0.84	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	67.63	17.98	25.90	8.58	8.58	3.79	2.64	0.66	2.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	65.07	14.59	24.50	7.67	8.41	4.49	3.18	0.75	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	67.26	10.92	26.64	7.86	10.16	4.79	1.53	0.77	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	63.77	16.55	23.09	7.36	8.79	5.72	1.64	0.61	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	56.01	12.29	24.38	6.85	8.66	4.43	1.61	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	58.34	14.05	31.33	9.18	9.18	5.94	1.35	0.27	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	63.14	12.96	26.65	5.76	10.80	4.08	1.92	0.24	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	58.11	12.94	27.76	8.23	10.35	4.23	2.59	1.18	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	62.07	14.64	24.59	6.73	8.78	4.10	2.78	1.02	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	60.74	15.82	25.73	6.54	9.70	5.27	0.84	1.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	63.29	19.41	25.18	8.92	9.62	5.07	2.62	1.22	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	64.65	13.45	27.91	8.23	12.45	3.01	2.21	1.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	62.58	17.45	28.15	8.61	11.63	5.35	1.40	0.93	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	68.61	15.11	26.63	10.32	7.68	3.60	2.40	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	58.42	16.39	24.74	11.03	12.22	4.47	2.98	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	72.05	15.08	34.47	9.57	11.97	3.83	1.44	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	65.92	19.21	27.30	7.68	9.71	4.45	1.82	0.81	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	66.61	16.60	27.05	8.61	7.17	5.94	1.84	0.82	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	84.06	16.68	31.80	6.23	12.01	10.01	2.00	1.11	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	209.88	125.93	153.91	83.95	0.00	111.94	13.99	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	69.91	10.65	32.65	5.68	9.58	12.77	1.77	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	74.89	10.60	32.14	4.97	7.29	4.31	1.33	1.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	98.16	38.59	62.92	31.88	14.26	22.65	5.03	3.36	18.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	67.97	19.75	29.85	10.10	6.89	3.67	0.46	0.92	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	84.27	8.75	40.84	6.16	11.99	5.83	1.30	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	95.07	8.67	37.90	9.31	9.31	10.28	3.21	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	72.30	13.52	26.72	16.03	11.63	8.49	2.83	1.57	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	40.89	7.76	27.50	2.82	9.17	10.58	0.00	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	62.25	11.22	17.95	3.36	5.61	7.29	1.12	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	33.44	15.92	11.94	17.52	9.55	14.33	0.80	1.59	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	38.05	12.91	11.55	9.51	6.12	4.42	1.70	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	53.61	5.52	22.42	7.15	6.50	4.87	1.95	1.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	52.54	8.52	23.78	3.19	8.87	4.26	1.42	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	16.16	64.66	48.49	32.33	80.82	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	142.15	110.56	118.46	39.49	47.38	47.38	7.90	7.90	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	73.61	7.80	16.58	3.90	4.88	3.41	3.41	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	51.57	5.45	17.36	1.98	2.48	4.46	1.49	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	59.58	8.44	20.64	0.94	6.10	1.88	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	60.61	6.95	16.56	2.65	5.96	3.64	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	65.27	6.19	19.80	2.17	3.40	4.95	1.24	0.93	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	57.48	7.95	19.57	2.45	2.45	3.97	0.61	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	61.29	12.04	16.63	3.17	6.02	5.23	1.27	0.48	0.48
Adipocyte - breast, donor2	11327-117E4	55.83	11.55	20.86	5.29	6.90	5.78	0.80	0.48	1.93
Adipocyte - omental, donor1	11473-119C6	59.67	13.10	16.29	5.34	3.82	2.42	1.53	0.64	0.38
Adipocyte - omental, donor2	11474-119C7	47.84	8.22	10.46	2.99	2.24	1.49	1.49	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	50.24	11.05	7.70	4.35	7.03	0.00	0.67	0.67	1.67
Adipocyte - perirenal, donor1	11476-119C9	49.76	12.12	8.29	4.47	3.83	2.55	0.64	0.00	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	56.07	6.60	9.90	4.40	3.30	3.30	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	37.48	5.87	11.74	0.90	2.71	1.35	0.90	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	46.40	5.04	9.38	4.17	6.95	0.87	1.56	0.52	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	78.62	17.80	20.14	6.45	12.32	1.96	2.15	0.78	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	65.89	14.16	9.27	4.12	5.40	1.80	0.51	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	68.58	16.17	12.27	12.82	8.92	1.67	1.67	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	81.12	25.86	14.70	3.53	6.47	3.53	2.94	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	85.50	26.14	21.88	9.17	10.86	1.93	2.98	2.01	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	75.20	14.52	18.72	4.20	6.13	3.23	1.94	1.61	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	72.51	10.13	13.33	8.53	7.46	2.13	1.60	1.07	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	76.79	25.04	13.35	3.90	4.45	2.78	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	60.72	14.14	7.49	8.32	7.90	1.66	1.25	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	58.27	12.81	16.83	4.52	5.78	3.52	0.50	2.01	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	63.16	13.09	11.78	6.54	4.58	1.31	2.29	1.96	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	49.93	15.53	10.05	7.00	4.26	1.83	3.04	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	61.66	8.40	17.90	5.75	3.31	0.88	0.22	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	44.82	2.87	10.04	1.79	3.23	0.36	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	22.76	2.40	3.59	3.59	4.79	0.00	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	62.97	15.29	21.41	7.02	7.74	0.72	1.44	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	30.12	5.02	5.02	1.67	3.35	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	53.62	11.51	16.44	5.34	6.37	2.67	1.23	0.82	0.21
Anulus Pulposus Cell, donor1	11248-116E6	72.20	9.84	14.42	4.81	6.52	1.49	2.98	0.57	0.57
Anulus Pulposus Cell, donor2	11463-119B5	52.17	8.08	14.20	5.39	5.14	0.73	3.67	0.73	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	39.09	9.44	9.44	3.15	9.88	5.84	0.45	0.45	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	49.93	9.55	13.46	5.21	7.38	0.87	0.87	0.43	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	49.23	4.28	8.56	0.00	6.42	8.56	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	38.56	8.97	12.26	2.99	8.37	3.29	0.30	1.49	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	39.20	7.59	3.79	3.79	8.85	1.26	0.00	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	30.36	9.24	5.94	1.32	2.64	3.96	1.32	0.66	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	41.59	8.12	10.72	3.90	6.17	2.60	1.30	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	41.26	11.17	8.74	2.91	11.17	4.37	0.00	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	36.23	7.72	10.69	2.97	5.94	2.97	1.78	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	34.65	6.78	12.05	3.01	9.42	2.64	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	32.66	14.51	10.16	3.63	7.26	3.63	0.00	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	33.85	10.03	6.27	2.51	2.51	3.76	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	53.54	12.19	15.49	4.45	5.27	1.32	2.14	0.66	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	38.21	8.19	8.19	2.73	4.09	1.36	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	42.37	8.44	15.38	4.07	6.94	4.22	0.90	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	41.79	13.93	10.18	1.61	11.25	4.29	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	36.46	10.20	11.34	4.53	8.88	4.35	0.76	0.38	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	52.66	11.76	12.03	1.34	6.41	2.94	1.07	0.27	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	38.04	8.78	12.68	2.93	9.75	2.93	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	36.32	10.95	9.79	2.99	8.29	4.15	0.66	0.50	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	38.42	10.81	8.41	2.40	4.80	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	10.62	7.08	0.00	3.54	3.54	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	42.88	11.66	9.09	3.43	9.43	4.12	1.03	0.51	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	20.97	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	36.89	11.65	8.25	7.77	7.77	2.91	1.46	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	36.81	9.87	10.25	4.93	9.11	1.14	0.76	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	38.76	9.69	4.85	1.21	6.06	6.06	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	31.35	6.84	10.83	3.99	4.56	2.28	0.57	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	40.19	12.19	8.55	1.50	8.12	2.14	0.64	0.43	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	32.78	8.26	8.26	2.58	5.42	3.36	1.03	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	43.17	10.32	15.01	1.88	9.38	3.75	1.88	2.35	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	40.52	11.25	16.40	3.54	7.40	4.50	0.32	0.32	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	37.10	8.56	6.42	2.85	4.28	3.57	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	30.42	7.02	12.28	2.92	7.60	2.34	0.58	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	39.14	10.54	6.62	1.51	5.72	5.42	0.30	0.00	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	28.51	7.13	14.26	1.19	9.50	3.56	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	39.67	4.58	8.65	4.07	8.14	3.56	1.02	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	42.53	10.44	13.50	2.55	7.39	4.33	0.51	0.25	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	38.76	7.62	6.99	1.91	4.45	5.08	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	36.68	7.77	9.06	2.59	12.08	3.45	1.29	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	44.45	12.28	8.04	3.39	9.74	5.08	1.06	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	34.80	7.54	7.54	1.45	6.09	5.22	1.45	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	45.35	13.23	8.50	3.78	9.45	4.72	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	42.04	10.51	11.19	2.37	7.97	4.24	1.19	0.51	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	4.63	4.63	2.32	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	42.25	12.68	14.79	0.00	6.34	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	44.17	9.86	14.15	4.72	8.36	5.15	0.86	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	53.55	8.42	10.23	3.61	3.61	9.02	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	37.91	9.48	9.48	1.46	9.48	2.92	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	49.65	12.64	13.33	4.60	7.82	2.99	0.69	1.15	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	17.85	7.65	7.65	10.20	10.20	2.55	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	58.47	8.39	13.73	5.85	8.64	3.81	1.27	0.25	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	54.71	11.97	13.42	4.95	9.91	3.10	1.65	0.21	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	45.90	5.81	11.93	3.98	7.65	3.67	1.84	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	59.27	8.60	16.73	3.82	9.56	2.87	0.96	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	47.23	8.87	12.64	3.77	6.65	5.10	0.67	0.44	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	32.04	6.10	9.15	1.53	6.10	0.00	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	39.88	6.65	13.29	2.77	8.31	6.65	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	47.40	10.86	15.89	4.50	7.15	5.56	1.85	0.00	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	48.70	9.09	14.54	2.18	5.45	5.09	0.36	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	44.34	10.56	5.53	5.65	3.68	0.12	1.47	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	40.22	7.87	10.61	3.25	4.62	0.51	1.88	0.34	0.51
Astrocyte - cerebellum, donor3	11661-122F5	17.20	6.29	5.45	5.24	3.78	1.05	0.63	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	47.06	21.26	11.15	14.64	4.88	2.44	4.18	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	67.94	18.28	13.59	10.68	7.28	5.99	0.65	0.81	2.10
Astrocyte - cerebral cortex, donor3	11392-118C6	82.34	18.05	22.97	12.98	9.10	4.77	2.54	0.89	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	120.99	41.86	29.59	15.37	20.41	3.33	2.98	1.03	4.01
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	129.79	45.23	36.21	17.16	19.67	4.13	4.01	1.88	2.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	132.12	44.27	33.68	16.05	17.52	2.96	2.50	2.05	2.05
Basophils, donor1	12241-129G9	149.86	36.88	32.17	13.86	8.11	3.14	2.09	0.52	1.05
Basophils, donor2	12242-129H1	213.95	88.03	26.70	16.60	10.46	2.16	5.77	2.16	1.44
Basophils, donor3	12243-129H2	126.12	38.66	29.55	13.23	12.05	2.94	3.09	1.62	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	34.50	3.88	3.67	3.23	2.80	0.22	0.65	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	27.89	3.66	1.83	0.46	1.37	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	93.26	21.52	0.00	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	42.68	9.41	10.04	1.88	3.77	1.26	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	36.60	3.54	9.77	3.33	3.74	0.42	0.83	1.25	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	45.14	8.29	8.06	2.99	4.61	1.84	0.23	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	63.52	7.02	5.58	4.14	2.88	3.24	0.00	0.00	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	200.13	34.73	52.35	66.37	12.88	12.78	8.24	1.44	2.16
Burkitt's lymphoma cell line:RAJI	10476-106I8	128.33	29.35	31.91	25.39	13.51	15.37	4.66	1.63	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	85.06	44.13	16.95	17.27	8.95	7.99	3.84	1.60	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	93.08	20.68	10.34	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	126.80	40.58	33.81	9.02	12.40	2.25	1.13	1.69	0.56
CD14+ Monocytes, donor2	11305-117B9	166.30	49.37	28.21	12.62	12.99	6.31	2.60	2.41	4.45
CD14+ Monocytes, donor3	11381-118B4	122.06	43.03	27.66	9.88	12.95	7.90	4.17	2.41	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	115.48	24.06	24.06	9.62	9.06	3.68	4.53	1.70	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	123.20	22.37	29.57	12.13	11.75	6.82	3.41	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	138.07	29.92	26.30	14.79	13.48	3.62	3.94	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	114.92	31.51	24.43	11.85	6.22	6.50	3.04	0.58	2.02
CD14+ monocytes - mock treated, donor2	11873-125C1	101.99	33.19	26.86	10.26	6.34	4.53	1.51	2.11	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	135.98	41.69	23.69	9.71	6.63	9.71	1.66	1.90	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	104.96	29.13	22.26	9.71	6.03	7.70	3.01	1.34	2.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	99.09	36.43	29.26	10.49	4.42	6.07	0.83	1.10	2.21
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	126.44	37.19	28.51	9.67	5.45	10.17	1.98	1.98	2.48
CD14+ monocytes - treated with BCG, donor1	11860-125A6	98.68	26.24	23.10	10.77	4.11	5.09	1.17	0.78	2.15
CD14+ monocytes - treated with BCG, donor2	11870-125B7	84.22	27.42	19.94	11.04	4.99	8.37	1.78	0.89	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	139.50	35.26	38.96	9.36	5.01	5.66	2.83	1.74	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	109.10	26.22	18.73	9.83	8.19	6.32	2.81	0.94	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	125.67	33.79	24.82	15.31	9.50	9.50	3.70	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	109.83	31.06	16.64	9.98	5.55	12.20	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	112.75	34.21	23.95	9.82	6.99	9.67	4.46	1.04	2.83
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	86.20	31.13	27.14	9.38	5.99	6.78	1.20	0.80	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	108.26	29.98	24.36	7.50	3.96	6.45	2.29	0.83	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	90.83	29.51	25.85	12.81	5.95	5.26	1.37	0.69	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	105.86	29.41	23.07	9.73	5.43	2.49	1.81	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	89.91	23.57	23.13	7.42	6.98	11.78	1.31	1.31	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	122.39	39.81	23.40	6.19	3.77	3.77	2.42	0.81	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	98.05	30.88	29.13	12.04	7.15	8.55	3.84	2.27	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	164.12	36.19	39.56	6.73	7.57	10.10	2.10	1.68	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	84.51	28.66	18.74	8.08	3.67	6.25	0.92	0.73	3.31
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	95.46	49.67	23.95	10.92	4.58	2.82	1.06	0.35	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	86.87	35.98	30.71	6.58	5.26	7.02	1.32	0.88	3.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	100.96	27.90	21.80	13.43	6.80	8.37	2.09	1.05	2.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	101.10	34.94	19.70	13.01	4.83	8.55	1.12	0.37	3.72
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	150.02	31.25	44.40	15.74	5.39	4.74	1.29	0.22	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	88.04	29.07	15.97	12.69	6.14	2.46	0.82	0.82	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	83.91	35.70	19.93	10.43	5.10	1.16	1.39	0.93	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	81.20	30.16	21.34	7.66	4.64	3.71	1.62	0.93	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	132.30	12.42	20.27	5.89	6.54	7.19	1.53	0.87	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	163.08	16.86	27.26	7.85	6.47	8.08	2.54	0.23	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	155.75	16.68	21.66	5.42	3.25	7.36	1.52	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	196.52	25.23	30.68	11.52	8.72	6.70	2.65	0.62	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	176.22	20.26	23.23	11.53	7.16	6.29	2.10	0.52	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	256.41	40.13	26.76	11.15	7.14	2.68	2.01	1.34	1.78
CD14-CD16+ Monocytes, donor1	11790-124B8	131.41	11.99	30.11	6.89	11.48	8.68	1.79	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	160.50	12.52	33.59	7.68	6.81	4.61	1.54	0.88	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	183.39	12.21	28.42	9.26	7.58	6.95	1.47	0.42	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	99.58	32.52	8.13	36.58	0.00	14.23	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	82.04	39.32	6.10	36.61	4.75	5.42	5.42	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	95.27	45.57	14.50	22.78	4.14	1.04	4.14	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	99.15	47.97	19.19	44.78	6.40	16.52	4.80	2.13	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	87.38	49.85	10.72	48.25	6.43	5.36	4.82	2.14	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	68.09	36.50	7.72	32.99	7.02	6.32	9.83	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	90.20	51.77	10.98	44.71	0.00	4.71	7.84	0.78	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	80.42	40.87	10.55	34.28	2.64	6.59	1.32	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	88.77	106.85	8.22	34.52	9.04	13.97	2.47	4.93	0.82
CD19+ B Cells, donor2	11624-122B4	66.74	92.85	13.78	26.84	5.80	20.31	4.35	7.98	2.18
CD19+ B Cells, donor3	11705-123B4	61.59	105.00	9.59	36.35	6.56	11.61	4.04	6.06	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	131.72	39.60	8.49	17.37	1.62	1.62	4.04	0.40	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	99.87	25.17	9.99	12.38	2.00	2.80	2.40	1.20	0.40
CD34+ Progenitors, donor1	11545-120B6	32.13	25.10	8.03	6.02	7.03	4.02	2.01	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	41.01	50.00	7.87	12.92	12.36	0.56	1.69	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	81.54	26.30	11.65	9.02	7.89	4.13	3.38	1.13	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	86.59	27.06	16.69	17.14	10.60	4.06	2.93	0.90	0.68
CD4+ T Cells, donor1	11225-116C1	136.75	99.62	35.35	34.63	27.49	3.57	7.50	3.21	0.36
CD4+ T Cells, donor2	11306-117C1	137.17	88.18	31.23	21.43	28.78	18.98	4.90	1.84	3.06
CD4+ T Cells, donor3	11382-118B5	151.28	82.04	35.07	22.87	15.86	21.35	3.35	2.74	3.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	136.81	29.61	15.82	10.98	5.10	1.28	2.55	1.28	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	168.67	29.65	22.24	10.33	8.09	8.09	3.37	1.57	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	237.16	33.92	27.60	11.21	8.91	10.06	1.44	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	109.52	53.57	29.87	28.92	15.17	7.59	1.42	1.90	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	123.61	60.40	27.39	35.82	16.15	14.05	3.51	3.51	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	141.74	26.37	13.18	13.18	19.78	13.18	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	99.86	29.34	17.49	9.68	9.39	6.36	2.31	0.58	1.73
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	136.08	35.76	21.18	8.98	10.17	14.23	3.90	1.02	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	155.72	25.15	29.18	7.74	8.06	18.22	1.93	0.64	1.77
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	151.97	39.90	22.41	15.69	8.97	12.55	4.03	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	161.42	46.12	28.30	26.55	12.58	9.78	2.80	1.40	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	243.75	56.32	32.12	20.24	7.48	5.72	2.64	1.32	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	94.03	29.09	13.49	5.06	4.22	1.69	2.95	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	113.03	28.88	17.04	8.93	8.93	13.09	2.29	1.04	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	130.64	25.06	17.04	6.68	4.34	15.04	1.34	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	82.94	51.94	19.04	20.40	8.97	3.81	3.26	1.63	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	113.62	73.43	17.15	26.26	15.54	5.36	5.36	1.61	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	121.94	55.59	17.93	14.35	8.97	7.17	1.79	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	112.00	38.20	15.21	13.17	8.72	7.60	3.52	0.37	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	104.41	27.08	16.46	9.53	9.75	5.85	2.82	0.22	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	127.14	33.20	17.86	13.24	8.83	6.30	1.89	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	101.63	45.00	26.29	19.21	17.19	7.58	4.55	2.53	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	125.21	41.16	20.80	16.46	16.03	5.20	3.90	2.60	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	152.97	51.86	20.48	13.51	7.41	6.54	1.31	2.18	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	119.76	48.99	21.28	31.18	13.36	7.92	6.93	1.48	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	90.47	44.31	12.00	24.00	11.08	5.54	3.69	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	115.85	48.85	8.37	11.17	12.56	15.35	0.00	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	108.00	52.34	16.06	24.92	10.52	0.83	6.37	1.66	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	111.90	64.54	16.69	28.22	11.04	0.98	4.42	2.45	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	157.08	55.44	12.32	20.02	6.16	1.54	6.16	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	123.91	45.84	14.68	26.86	14.32	3.22	4.30	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	121.88	78.94	12.46	24.93	13.85	4.15	1.38	4.15	0.00
CD8+ T Cells, donor1	11226-116C2	118.84	93.96	47.80	20.30	21.61	8.84	4.58	2.29	1.64
CD8+ T Cells, donor2	11307-117C2	108.12	96.11	32.29	18.02	16.89	11.26	3.00	1.50	5.26
CD8+ T Cells, donor3	11383-118B6	119.93	85.59	34.34	28.28	22.47	18.18	4.04	4.29	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	103.91	13.99	27.53	5.51	7.11	2.52	0.92	2.06	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	100.17	11.74	27.32	3.83	4.79	1.68	0.00	1.20	1.68
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	99.04	16.14	22.98	3.83	5.75	3.01	0.55	0.82	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	101.77	7.21	25.22	7.21	6.00	2.70	0.60	0.90	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	106.31	17.04	33.60	5.52	6.48	3.36	0.72	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	92.32	13.87	36.38	6.14	10.23	3.18	0.45	0.45	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	84.09	11.08	28.68	5.00	3.04	1.96	0.87	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	89.23	14.74	21.85	3.68	3.42	2.63	1.05	0.53	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	93.81	11.26	23.92	3.75	6.10	1.64	0.23	1.17	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	89.36	12.98	32.60	7.55	5.43	2.42	0.60	2.11	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	96.16	15.40	26.73	4.65	8.13	2.91	0.58	2.03	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	82.33	12.26	27.71	6.93	8.26	0.53	0.00	2.13	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	91.49	18.82	32.39	10.94	4.82	2.63	0.88	1.31	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	97.46	18.67	34.61	6.38	7.29	3.19	0.46	3.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	70.86	19.39	23.87	5.97	5.22	0.75	0.00	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	104.81	12.97	29.89	3.24	9.00	1.80	0.36	1.08	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	95.24	15.25	27.62	4.03	8.34	3.45	0.86	0.86	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	98.52	17.44	31.35	4.48	6.84	1.65	0.47	2.12	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	85.88	14.58	28.20	4.12	6.34	1.27	0.32	0.63	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	104.26	12.30	27.99	3.69	4.92	2.77	0.00	2.15	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	96.18	14.43	28.53	5.13	4.49	2.56	0.32	1.28	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	75.35	10.71	27.54	5.74	4.59	1.15	0.38	2.29	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	90.64	16.16	27.98	5.12	2.36	1.58	0.39	1.18	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	89.26	12.10	24.21	7.56	1.51	1.51	1.51	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	98.76	22.48	30.51	8.83	1.61	1.61	0.80	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	111.91	28.68	36.37	7.69	4.90	4.90	0.70	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	94.16	37.06	47.08	6.01	6.01	3.01	1.00	5.01	1.00
Cardiac Myocyte, donor1	11525-119I4	98.70	16.45	14.62	1.83	14.62	3.66	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	54.35	5.93	9.88	7.91	5.43	2.96	0.99	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	89.24	7.16	36.41	7.26	20.20	2.95	1.89	0.00	0.42
Chondrocyte - de diff, donor1	11261-116G1	62.75	6.24	11.44	3.47	15.95	1.39	1.04	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	31.98	7.46	8.88	0.71	4.98	1.07	1.42	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	56.55	8.53	16.50	4.44	9.78	4.89	1.37	0.11	0.46
Chondrocyte - re diff, donor2	11339-117F7	48.34	17.01	16.11	1.79	4.48	0.90	1.79	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	55.00	9.30	16.18	4.04	4.45	6.07	2.02	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	68.63	19.51	23.53	12.05	10.10	3.56	2.87	0.92	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	81.02	16.46	30.57	15.39	9.83	7.91	1.71	0.64	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	81.86	16.20	29.29	16.28	11.06	5.31	3.45	1.42	1.50
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	57.59	23.48	10.36	8.62	5.14	0.55	3.21	0.83	0.73
Corneal Epithelial Cells, donor1	11526-119I5	35.13	5.27	5.05	1.98	2.20	1.10	0.00	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	42.09	5.69	7.96	1.14	0.00	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	39.37	6.90	9.97	2.30	3.32	1.79	1.28	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	95.26	15.52	27.41	3.80	6.77	3.14	1.49	0.99	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	82.32	11.99	29.65	1.89	6.31	3.15	4.10	1.26	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	3.45	20.70	3.45	3.45	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	81.75	12.42	24.41	2.92	5.94	4.64	1.73	0.43	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	79.94	63.55	14.35	19.47	11.27	4.10	4.44	1.02	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	63.33	54.84	16.97	16.97	15.02	2.61	5.88	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	59.04	74.04	7.26	18.39	15.97	0.97	4.84	0.48	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	47.70	9.51	15.84	4.00	7.50	1.00	1.50	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	41.66	5.87	10.56	4.69	8.21	0.00	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	70.98	13.29	23.47	5.09	10.46	0.57	0.85	0.28	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	66.45	20.45	16.12	3.93	8.65	0.39	0.39	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	53.81	11.93	24.43	5.53	13.38	0.58	0.87	1.16	0.58
Endothelial Cells - Artery, donor2	11341-117F9	83.99	12.94	35.06	5.65	13.18	7.29	1.18	0.47	1.18
Endothelial Cells - Artery, donor3	11413-118E9	75.03	8.41	26.65	4.03	9.47	2.98	0.70	0.53	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	62.51	11.53	15.96	4.43	10.86	1.99	0.89	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	63.29	10.04	19.78	5.48	12.17	1.83	0.91	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	60.33	15.22	17.76	7.33	6.20	0.28	2.82	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	46.35	9.81	10.40	2.97	12.18	0.59	1.49	0.30	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	43.22	5.21	9.37	1.56	4.69	0.00	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	68.48	7.94	20.13	6.10	11.91	3.54	0.57	0.43	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	80.82	22.81	21.61	7.60	16.00	1.20	2.00	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	44.55	11.01	11.53	0.52	10.48	4.19	0.52	1.05	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	126.23	23.86	30.44	10.81	14.66	3.23	1.86	0.37	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	90.82	19.34	21.07	7.82	10.65	1.74	2.17	0.43	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	115.78	23.33	29.92	8.18	14.78	2.44	2.56	0.98	0.49
Endothelial Cells - Vein, donor1	11267-116G7	39.81	14.79	13.65	0.00	6.83	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	39.12	16.76	7.68	1.40	6.99	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	51.97	13.97	16.17	5.97	7.54	3.14	1.10	0.63	0.31
Eosinophils, donor1	12244-129H3	106.73	152.47	60.99	30.49	15.25	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	356.46	79.21	74.26	11.55	19.80	8.25	3.30	0.00	1.65
Eosinophils, donor3	12246-129H5	306.75	17.83	49.94	10.70	17.83	7.13	7.13	3.57	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	29.81	3.66	5.86	2.20	1.95	0.00	0.98	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	4.16	8.32	2.08	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	32.54	32.54	0.00	16.27	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	57.47	14.37	20.12	4.11	9.44	6.98	1.64	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	35.15	5.47	21.13	1.42	9.53	0.66	0.66	0.66	1.09
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	66.30	10.94	20.58	5.74	9.97	1.84	2.06	0.33	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	67.07	11.64	32.14	5.46	11.64	2.91	1.21	0.85	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	61.41	5.87	31.12	1.36	13.78	1.77	0.82	0.00	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	82.79	12.02	35.23	5.38	15.29	6.33	0.63	0.32	1.90
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	54.02	5.27	11.86	1.84	7.64	0.26	0.79	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	71.42	14.28	24.91	6.98	9.63	8.30	1.66	0.66	1.33
Fibroblast - Cardiac, donor1	11268-116G8	65.78	9.98	25.40	4.54	18.60	0.91	2.72	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	53.81	9.10	17.43	5.31	14.40	0.76	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	43.69	9.78	19.40	3.47	9.62	3.15	1.10	0.63	0.79
Fibroblast - Cardiac, donor4	11452-119A3	98.51	10.31	25.16	3.33	11.21	0.91	0.91	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	83.38	17.64	22.72	7.23	14.21	2.92	2.03	0.13	2.28
Fibroblast - Cardiac, donor6	11460-119B2	73.07	14.86	15.31	5.00	6.37	1.97	1.36	0.45	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	54.80	12.19	11.12	9.78	5.23	0.00	1.07	0.40	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	61.69	10.35	13.37	7.33	8.20	2.59	1.73	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	93.75	16.11	10.25	14.65	2.93	8.79	4.39	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	80.03	21.91	24.22	6.46	9.46	0.69	1.61	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	113.30	15.26	20.86	10.18	13.06	1.70	3.90	0.34	0.51
Fibroblast - Dermal, donor1	11269-116G9	71.14	11.50	19.72	6.34	10.80	3.29	1.41	0.94	1.41
Fibroblast - Dermal, donor2	11346-117G5	67.92	8.02	12.74	8.49	7.55	0.47	1.42	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	103.60	14.39	36.75	8.46	15.47	9.91	2.18	0.36	1.57
Fibroblast - Dermal, donor4	11450-119A1	112.25	16.05	24.19	9.61	10.51	2.94	2.49	0.90	2.60
Fibroblast - Dermal, donor5	11454-119A5	117.93	24.60	24.07	9.94	9.59	2.62	2.97	1.40	1.22
Fibroblast - Dermal, donor6	11458-119A9	117.43	21.76	23.71	8.61	6.98	2.60	2.11	1.14	1.95
Fibroblast - Gingival, donor1	11237-116D4	70.59	11.87	29.57	6.04	10.20	3.54	0.62	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	101.92	13.62	34.06	7.34	15.98	2.10	1.31	0.79	1.31
Fibroblast - Gingival, donor2	11318-117D4	94.09	15.68	24.38	7.91	6.59	9.62	1.84	0.79	1.45
Fibroblast - Gingival, donor3	11394-118C8	124.73	22.14	28.62	9.96	17.40	3.29	1.84	0.87	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	70.64	16.62	20.78	4.16	11.43	3.12	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	75.24	10.40	23.96	7.22	11.45	5.29	1.41	0.53	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	100.24	18.40	33.21	10.60	12.00	3.43	1.09	0.47	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	93.44	15.42	21.77	7.30	8.11	2.16	1.22	0.54	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	82.57	8.82	26.47	4.59	9.17	0.00	1.76	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	98.86	16.38	23.84	5.56	9.65	2.19	1.90	0.73	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	94.77	16.23	22.23	6.68	8.59	2.59	2.32	0.27	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	127.35	24.02	38.28	9.98	15.25	1.97	3.18	0.66	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	76.30	12.18	18.34	6.31	7.63	1.32	2.79	0.15	0.59
Fibroblast - Lung, donor1	11270-116H1	29.91	5.44	2.72	4.08	4.08	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	85.05	19.40	13.43	10.45	2.98	1.49	4.48	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	83.36	17.09	20.26	9.50	9.50	4.85	1.27	2.53	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	62.48	18.33	12.50	5.00	6.66	0.00	2.50	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	47.55	2.80	13.99	1.40	1.40	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	32.19	2.80	8.68	0.56	3.92	0.56	0.28	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	116.11	16.64	26.39	4.06	8.53	0.00	2.03	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	43.94	3.99	3.99	7.99	3.99	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	89.34	5.96	23.83	5.96	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	90.59	13.00	16.88	9.12	6.79	6.60	1.75	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	126.35	19.26	27.00	13.20	10.92	1.97	1.67	1.21	1.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	140.14	17.44	47.73	11.32	18.67	0.31	2.75	1.22	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	82.43	16.79	24.04	4.20	11.83	1.53	1.14	1.53	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	78.84	11.34	31.86	4.05	8.37	6.75	0.54	0.54	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	77.35	14.73	21.80	3.48	5.80	1.51	1.28	0.70	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	91.63	9.17	32.83	6.19	9.51	3.32	1.66	0.88	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	62.79	12.19	19.51	7.11	5.08	0.41	1.22	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	48.78	8.69	11.36	4.01	5.35	2.00	0.67	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	87.37	9.49	19.37	5.54	8.70	5.54	3.16	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	66.88	6.35	13.30	3.97	10.72	0.40	1.19	0.40	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	50.27	8.35	12.97	5.68	7.46	0.71	1.24	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	76.86	10.64	22.27	4.14	8.67	1.77	0.79	0.99	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	47.54	4.51	9.33	2.41	7.52	0.30	0.90	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	65.96	13.82	15.33	6.05	12.20	0.43	2.16	0.43	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	50.61	4.81	11.89	0.51	7.85	0.51	0.76	0.25	1.01
Fibroblast - skin normal, donor1	11553-120C5	60.22	10.99	18.87	5.09	7.06	1.80	1.31	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	54.74	5.41	13.23	1.60	6.82	1.60	0.60	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	52.44	9.64	10.95	3.42	7.94	0.40	1.21	0.70	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	65.28	7.86	12.09	3.93	8.46	0.60	1.21	0.30	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	71.91	11.60	21.95	5.14	8.28	2.40	1.99	0.58	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	62.23	11.28	9.40	5.13	6.84	0.51	1.37	0.51	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	42.04	5.91	11.17	1.97	6.57	0.33	0.99	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	45.91	12.04	8.52	5.22	9.16	1.49	0.96	0.53	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	71.52	11.13	17.71	4.72	6.58	0.84	0.67	0.84	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	42.03	11.13	17.56	5.96	4.08	2.51	1.41	0.31	3.45
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	88.64	88.64	44.32	0.00	0.00	0.00	0.00	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	54.03	13.07	5.23	4.36	0.87	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	67.78	18.20	25.48	4.68	7.97	3.47	2.77	1.04	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	75.47	10.15	16.13	5.99	7.03	3.38	1.04	1.04	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	71.80	19.42	24.78	6.13	9.20	2.04	1.79	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	63.54	9.95	18.37	10.72	5.36	3.06	2.30	3.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	72.74	11.49	19.14	11.49	4.47	5.10	0.64	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	103.84	20.82	13.69	18.26	5.99	10.27	1.71	1.14	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	100.93	30.06	15.44	20.41	5.79	6.62	3.31	1.10	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	63.02	17.81	14.38	9.82	5.71	7.76	2.51	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	98.87	20.61	15.26	16.44	6.14	7.33	3.76	0.59	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	79.04	25.90	15.86	16.65	6.87	8.19	3.17	0.26	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	66.21	13.37	17.94	10.44	8.48	4.89	1.96	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	93.75	14.15	11.94	13.27	2.65	7.52	1.77	0.00	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	90.59	15.26	9.19	13.99	6.92	5.65	1.41	0.28	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	81.52	17.49	12.56	18.47	8.25	3.45	1.60	0.86	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	88.38	11.28	13.16	7.52	6.98	4.84	3.49	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	87.59	15.36	12.64	19.82	8.05	2.60	2.35	0.37	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	93.16	17.86	13.98	20.07	5.54	3.88	1.94	0.55	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	87.62	8.95	12.81	12.81	6.71	3.25	1.42	0.20	1.63
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	72.56	13.69	13.46	12.09	10.27	1.60	0.46	0.91	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	71.87	14.33	10.96	15.57	6.60	4.11	1.25	0.12	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	99.45	8.52	12.46	16.17	6.99	3.50	1.09	0.44	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	55.55	17.43	12.11	16.84	7.39	2.95	1.48	0.00	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	65.33	22.41	9.06	18.44	11.76	4.13	1.11	0.32	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	71.05	14.97	10.28	17.20	6.26	2.90	0.45	0.45	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	65.73	22.38	13.71	18.75	11.69	4.84	2.22	1.01	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	53.78	23.75	11.54	16.62	10.69	4.24	2.37	0.85	1.87
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	86.46	21.19	20.04	21.81	7.45	1.06	3.10	0.62	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.35	14.98	8.53	13.32	7.39	1.04	2.39	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	41.84	17.42	6.32	8.88	4.95	0.85	1.02	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	60.42	27.22	8.08	19.25	11.18	2.32	1.99	0.66	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	74.71	20.88	13.81	20.13	6.99	1.83	1.58	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	69.83	21.23	10.62	10.21	6.33	0.61	1.23	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	54.67	20.42	8.05	20.84	10.93	3.51	1.65	0.21	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	63.76	26.98	7.72	20.75	11.76	4.04	2.54	0.58	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	59.20	17.01	13.51	11.51	12.34	2.84	1.33	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	57.97	16.09	9.48	16.31	10.58	4.63	2.20	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	70.72	24.72	9.84	20.17	15.25	3.69	3.20	0.25	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	54.95	21.72	11.99	16.21	6.16	1.46	0.65	0.49	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	73.44	17.00	6.09	18.60	8.98	3.85	3.85	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	47.19	21.98	9.29	12.79	10.33	2.18	2.18	1.23	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	56.15	16.45	8.38	9.97	12.50	3.48	1.42	0.32	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	52.91	24.02	8.21	10.34	10.34	2.43	0.91	0.30	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	51.01	21.12	9.62	11.50	9.20	3.66	1.46	0.63	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	54.67	13.61	7.25	13.39	11.20	3.51	1.32	1.54	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	50.50	21.60	9.82	16.83	8.14	3.09	2.24	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	46.76	22.22	10.18	6.85	11.48	2.13	0.83	1.02	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	46.53	17.38	10.16	7.49	9.63	4.28	0.80	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	55.69	21.27	12.70	7.34	9.33	2.45	1.38	1.22	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	41.45	17.23	11.79	4.40	10.75	2.33	1.30	0.39	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	53.94	18.70	10.57	8.40	13.55	2.17	1.36	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	58.44	18.62	10.69	10.32	10.51	2.21	2.03	0.37	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	64.70	18.20	12.94	8.55	11.84	2.85	1.10	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	93.22	25.79	12.89	9.92	19.83	1.98	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	58.17	20.05	15.17	7.91	9.10	2.77	1.58	0.66	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	60.53	18.56	11.70	9.48	8.27	1.41	0.81	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	69.89	24.65	15.50	18.81	11.95	0.00	2.80	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	78.83	19.71	6.17	16.52	4.38	0.40	2.59	0.80	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	90.13	20.03	8.47	14.33	5.08	2.62	2.16	1.08	2.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	96.77	28.03	10.64	18.00	7.98	3.07	2.66	0.61	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	47.88	6.57	9.70	7.82	5.01	5.32	2.82	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	53.97	13.85	6.50	9.04	2.54	3.39	1.98	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	65.03	14.30	11.07	11.07	1.38	10.15	1.38	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	81.67	7.42	12.37	2.47	4.95	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	64.98	10.06	8.90	9.67	5.03	4.64	3.09	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	68.99	19.25	8.02	16.04	4.81	11.23	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	74.77	26.08	6.96	8.69	1.74	6.96	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	52.08	18.23	7.49	10.09	7.49	7.81	2.93	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	54.36	13.59	9.47	10.30	3.71	2.88	2.06	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	69.98	16.66	6.66	13.33	10.00	23.33	10.00	0.00	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	53.41	13.98	8.39	8.95	4.47	4.75	3.08	0.28	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	53.93	14.05	7.19	12.42	5.23	4.58	1.96	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	62.91	12.58	10.90	11.74	5.03	10.07	1.68	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	60.12	20.04	8.91	13.04	3.82	4.13	2.86	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	46.87	18.34	5.77	9.51	9.17	6.11	2.38	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	10.44	6.26	12.53	0.00	4.18	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	94.50	31.50	8.02	24.05	6.87	6.87	2.29	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	49.13	14.80	6.22	11.84	3.26	5.03	3.26	0.30	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	49.13	10.16	16.94	6.78	6.78	15.25	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	54.26	15.33	11.18	11.18	9.11	7.46	2.07	0.41	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	57.76	19.79	14.73	12.43	6.90	5.06	1.61	0.46	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	21.07	21.07	10.54	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	53.43	11.92	11.15	10.38	5.38	4.23	0.77	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	61.93	11.41	10.11	12.71	6.85	4.24	1.30	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	56.18	10.03	11.37	8.03	5.35	4.68	0.67	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	83.60	18.88	10.40	18.88	4.62	5.01	2.70	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	97.57	36.63	32.86	23.28	15.06	8.56	1.71	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	77.03	9.94	12.42	12.42	0.00	14.91	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	77.86	20.76	7.08	21.71	10.85	3.77	3.77	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	94.75	22.33	9.66	23.54	7.24	9.66	1.81	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	70.20	19.33	7.12	17.29	10.17	5.60	0.51	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	57.43	15.95	10.37	21.14	8.77	7.18	2.39	0.00	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	67.10	19.24	8.39	28.12	9.87	10.85	2.96	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	74.37	14.17	11.80	14.17	10.62	14.17	1.18	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	75.26	23.34	8.17	19.25	5.83	7.58	1.17	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	70.22	19.31	5.27	24.58	7.02	5.71	0.88	0.44	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	91.55	20.34	5.93	16.11	5.93	9.32	2.54	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	42.38	16.12	8.95	10.74	8.36	8.36	2.39	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	41.73	14.07	8.25	8.25	6.31	4.37	1.46	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	61.63	6.85	15.98	4.57	4.57	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	63.62	9.15	33.68	5.82	14.55	7.48	2.49	0.83	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	40.48	7.87	12.37	0.00	5.62	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	114.50	8.56	39.96	7.61	14.27	8.25	1.59	0.00	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	74.78	5.85	17.96	6.27	10.44	2.92	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	56.98	15.43	19.61	4.18	7.54	6.73	1.28	0.70	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	71.91	17.89	23.29	4.56	6.25	7.60	0.84	0.34	1.86
Hep-2 cells mock treated, biol_rep3	11900-125F1	63.25	17.29	20.25	6.14	4.32	6.60	0.68	0.46	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	57.28	15.41	25.03	5.79	8.09	6.23	0.77	0.66	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	61.89	15.69	20.42	6.66	6.45	6.02	1.07	1.07	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	67.81	16.58	21.96	4.74	4.95	4.74	1.08	0.86	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	42.97	12.33	14.82	5.36	6.73	5.85	0.62	0.75	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	41.69	13.90	16.47	4.12	4.46	5.15	1.20	0.69	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	46.77	15.38	14.10	4.16	4.81	3.84	0.32	0.32	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	47.57	11.19	6.72	5.60	7.28	0.56	2.24	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	57.56	9.09	19.91	2.16	6.06	1.73	0.00	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	76.67	10.58	13.22	7.93	5.29	2.64	0.00	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	84.30	7.05	32.10	4.59	9.52	1.41	1.41	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	44.32	5.09	17.44	6.54	4.36	0.73	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	80.25	10.84	20.81	9.09	8.57	5.94	0.87	0.52	0.52
Hepatocyte, donor1	11523-119I2	75.06	25.42	20.58	3.63	8.47	3.63	2.42	1.21	0.00
Hepatocyte, donor2	11603-120I1	154.06	43.09	26.93	12.93	4.31	9.70	6.46	1.08	0.00
Hepatocyte, donor3	11684-122I1	54.60	28.22	14.72	6.75	5.52	1.84	3.07	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	80.93	24.15	15.66	16.32	3.92	7.83	1.31	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	90.54	20.80	30.76	15.56	9.96	3.67	2.10	0.87	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	77.11	11.53	23.05	12.49	15.78	2.06	2.33	0.41	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	0.00	6.37	3.18	0.00	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	2.77	5.54	0.00	4.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	0.00	5.01	2.50	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	5.13	7.69	0.00	7.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	4.57	0.00	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	3.25	4.87	0.00	3.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	28.34	3.33	3.33	1.67	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	32.68	14.52	3.63	0.00	0.00	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	26.47	1.32	3.97	0.00	2.65	0.00	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	32.15	4.43	8.87	3.33	1.11	0.00	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	23.93	5.04	4.41	0.00	3.15	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	3.09	6.19	1.55	0.00	0.00	3.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	26.49	8.40	4.52	0.65	4.52	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	25.76	8.05	1.61	0.00	3.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	23.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	28.52	4.89	3.26	0.81	1.63	0.00	0.81	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	15.53	2.52	5.04	0.84	0.84	0.00	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	24.11	4.82	1.61	0.80	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	16.62	4.62	8.31	0.92	3.69	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	27.38	2.36	1.89	1.42	1.89	0.00	0.47	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	11.79	1.81	4.53	1.81	0.00	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	29.06	5.38	6.46	1.08	6.46	0.00	0.00	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	3.81	6.35	0.00	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	22.32	3.19	4.46	0.00	1.28	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	1.82	9.11	0.00	5.47	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.85	2.86	4.28	0.00	0.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	0.00	6.64	0.00	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	25.00	5.86	6.79	0.62	3.09	0.31	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	7.02	7.02	5.27	3.51	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	3.14	3.14	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	22.25	5.56	5.56	0.70	4.17	0.00	0.70	0.70	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	30.98	2.21	4.43	0.00	2.21	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	9.73	0.00	3.24	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	19.18	6.98	1.74	0.87	0.87	0.00	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	22.50	9.00	9.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	3.48	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	20.27	6.40	1.07	0.00	1.07	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	6.93	6.93	1.39	0.00	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	0.00	0.00	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	20.25	6.44	2.76	0.00	3.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	9.08	3.03	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	6.21	0.00	6.21	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	4.23	1.06	2.11	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	92.45	11.26	22.44	4.49	6.53	1.71	1.63	0.65	0.49
Keratinocyte - epidermal, donor2	11349-117G8	24.01	5.86	8.20	0.59	2.34	0.00	1.76	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	90.78	16.28	22.34	6.72	9.18	5.77	1.80	1.14	0.95
Keratinocyte - oral, donor1	11251-116E9	120.90	15.10	20.55	10.33	9.19	2.84	2.16	0.79	1.48
Keratocytes, donor1	11527-119I6	71.86	29.23	23.04	6.19	8.25	0.34	1.38	0.34	0.00
Keratocytes, donor2	11607-120I5	35.15	7.03	16.41	2.34	2.34	1.17	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	117.57	20.75	27.27	5.73	16.80	4.35	1.38	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	101.10	4.40	0.00	10.99	2.20	0.00	8.79	0.00
Lens Epithelial Cells, donor1	11529-119I8	87.38	8.63	25.89	8.63	9.71	3.24	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	67.93	24.91	16.03	20.99	9.46	3.00	4.73	0.35	0.46
Lens Epithelial Cells, donor3	11690-122I7	98.08	14.93	37.44	9.79	23.71	0.71	2.32	1.11	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	61.30	7.35	19.33	6.28	12.33	1.90	1.07	0.12	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	41.30	6.98	9.49	3.35	10.05	3.07	2.23	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	65.96	9.13	17.47	5.82	13.07	7.71	1.26	0.31	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	51.62	7.53	16.67	3.23	6.45	2.15	0.54	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	43.49	6.93	10.09	5.36	8.51	1.89	1.58	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	40.32	4.64	9.92	4.20	5.07	3.77	1.40	0.22	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	72.64	9.03	13.54	6.16	9.85	3.69	2.05	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	23.51	3.54	5.31	2.53	5.81	3.54	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	47.29	5.77	12.25	6.05	8.59	4.08	1.27	0.14	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	51.42	7.52	14.24	3.96	3.96	2.77	0.79	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	37.03	7.17	9.50	6.01	8.72	3.88	0.78	0.39	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	24.81	2.78	5.37	2.22	4.07	0.93	0.37	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	61.32	8.71	11.85	4.53	5.92	3.83	1.39	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	41.74	6.68	10.26	4.53	10.02	2.15	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	39.83	7.00	10.44	3.57	6.59	3.85	1.51	0.27	1.51
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	53.58	12.32	12.01	5.24	8.31	4.00	0.31	0.62	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	28.99	4.36	5.30	4.36	6.55	2.81	0.62	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	44.28	4.94	10.61	4.76	7.69	2.56	1.83	0.18	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	46.40	11.85	10.20	5.59	9.87	1.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	31.34	4.98	5.56	3.51	3.51	1.76	0.29	0.29	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	35.10	3.49	7.72	2.99	5.48	2.49	0.75	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	43.65	8.73	15.52	4.36	6.79	4.85	2.91	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	33.39	5.92	8.62	4.58	6.46	3.23	0.81	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	44.05	8.48	11.81	3.94	9.23	4.54	0.91	0.45	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	35.25	6.74	9.33	4.67	4.15	2.59	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	39.37	7.75	12.35	5.23	10.26	4.40	1.47	0.00	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	39.55	7.97	9.17	5.56	9.62	3.01	0.75	0.30	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	47.46	11.01	14.45	2.75	8.94	3.44	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	35.94	9.22	10.72	4.33	8.84	2.26	0.94	0.38	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.95	4.88	7.00	3.71	5.83	2.23	0.74	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	62.03	8.72	14.05	4.36	7.75	4.85	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	31.76	6.95	5.95	4.96	5.62	2.32	0.99	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	30.48	5.82	7.19	3.96	5.33	2.85	1.36	0.00	0.87
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	68.86	16.29	22.21	3.70	9.26	7.03	1.11	0.74	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	42.75	8.15	8.65	3.46	5.19	1.48	0.00	0.49	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	33.00	6.19	9.35	3.85	6.74	2.89	1.24	0.00	1.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	66.26	5.79	18.33	3.22	8.04	3.22	1.29	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	47.17	12.17	13.09	4.26	9.43	4.56	1.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	55.29	10.92	14.14	3.78	8.68	4.20	1.82	0.14	2.10
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	60.80	10.67	14.93	4.62	10.31	3.91	0.00	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	22.30	6.30	5.82	2.91	3.88	0.97	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	29.41	5.14	7.78	2.02	5.14	1.09	0.62	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	51.21	12.53	15.04	4.66	6.80	6.45	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	36.26	6.21	11.11	4.57	6.53	1.96	0.65	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	24.25	4.00	8.00	2.12	5.18	2.83	0.94	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	63.36	10.77	21.41	5.07	8.54	1.49	1.49	0.12	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.77	4.61	6.40	2.05	4.10	0.51	0.51	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	45.35	6.27	13.43	3.28	12.83	2.39	0.90	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	135.96	6.80	18.13	40.79	9.06	2.27	18.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	115.84	6.90	40.66	29.92	24.55	9.21	6.14	1.53	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	100.94	4.45	33.40	34.14	20.78	1.48	5.94	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	112.13	11.00	26.23	19.04	11.00	7.62	5.92	0.42	2.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	96.36	10.55	27.43	30.24	14.07	7.03	4.22	0.00	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	103.67	11.21	42.96	24.28	16.81	1.87	2.80	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	84.50	10.31	21.13	17.00	7.21	4.12	4.64	0.52	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	92.78	5.95	30.93	19.03	17.84	2.38	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	94.77	11.08	36.87	30.08	14.02	0.90	6.79	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	137.27	18.61	35.19	38.97	12.51	14.54	11.34	0.87	4.07
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	146.31	19.36	45.92	53.12	28.36	18.91	8.55	0.45	3.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	120.31	10.70	37.67	32.92	15.58	1.63	10.16	0.27	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	121.19	10.78	27.73	31.84	8.73	10.27	7.19	0.51	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	147.14	19.05	50.81	50.46	28.58	8.12	7.06	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	142.59	15.33	43.98	58.63	29.32	10.66	5.33	0.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	101.37	10.19	34.13	30.56	12.73	9.17	6.11	1.53	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	140.87	17.34	42.16	56.03	27.21	12.54	10.14	0.53	3.47
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	140.57	16.25	41.76	46.67	25.89	15.12	6.80	0.38	3.59
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	119.03	9.20	34.36	26.38	9.20	4.29	8.59	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	104.37	14.68	47.29	35.06	22.02	4.08	7.34	0.82	5.71
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	140.15	20.20	43.52	41.65	26.45	16.03	9.58	0.21	3.75
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	135.65	19.62	45.96	38.68	16.82	18.22	6.17	1.40	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	115.40	16.49	46.37	36.06	13.39	0.00	6.18	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	163.44	14.22	38.90	45.29	18.87	18.58	9.29	0.29	4.94
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	135.71	15.84	29.30	34.97	11.36	16.74	5.68	0.60	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	137.76	16.60	45.37	45.92	18.26	10.51	4.98	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	121.60	11.31	28.99	28.28	12.02	4.95	7.07	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	126.86	15.86	23.97	32.08	10.69	8.48	5.53	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	77.14	4.61	32.24	31.08	9.21	3.45	8.06	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	112.44	8.44	26.48	26.48	13.82	6.14	4.22	0.00	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	91.71	6.23	27.17	15.29	7.93	6.79	5.10	0.57	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	98.46	14.77	24.61	36.10	16.41	4.10	4.92	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	91.28	7.23	26.66	23.05	10.85	4.52	5.42	0.45	3.16
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	111.31	12.21	24.42	25.14	5.03	10.05	7.90	0.00	4.31
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	125.48	11.95	39.59	44.81	17.18	4.48	9.71	0.00	4.48
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	108.88	10.78	37.16	31.96	13.75	5.20	5.57	0.37	4.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	117.59	11.63	27.14	30.15	7.32	6.46	8.18	0.00	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	94.19	16.27	31.68	36.82	11.13	4.28	5.99	0.00	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	124.28	13.66	34.98	35.65	15.99	5.33	7.66	0.67	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	91.70	12.07	25.34	19.31	4.83	6.64	7.24	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	71.10	10.66	35.55	34.84	11.38	2.84	4.98	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	93.49	12.37	21.31	28.87	15.12	6.19	6.19	0.34	4.47
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	103.06	9.66	22.54	22.01	4.29	8.05	6.98	0.00	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	96.96	12.12	31.65	24.91	10.77	1.35	4.71	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	122.60	14.45	28.52	34.08	17.41	8.15	6.30	0.00	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	115.13	10.47	24.42	24.42	8.14	0.00	9.30	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	81.45	9.52	23.27	22.21	9.52	1.06	4.23	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	114.04	8.40	27.21	26.41	8.00	6.40	10.80	1.20	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	98.13	13.81	25.44	17.44	10.18	1.45	5.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	98.11	8.43	29.89	24.53	19.16	2.30	6.13	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	105.56	10.36	33.54	23.18	17.26	2.96	7.89	0.00	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	120.44	10.35	27.29	24.46	4.70	0.94	4.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	109.11	8.05	33.69	30.67	19.11	4.53	8.05	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	100.04	10.81	25.23	23.43	13.52	5.86	2.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	104.99	13.77	17.21	8.61	6.88	5.16	5.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	102.43	13.36	29.84	26.28	13.81	4.01	6.68	0.45	5.79
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	125.52	15.25	30.89	21.12	13.29	7.04	8.99	0.00	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	124.69	11.88	20.45	23.75	8.58	3.30	6.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	108.97	11.94	33.73	22.83	24.39	8.82	5.71	0.52	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	135.65	14.00	35.01	34.57	21.00	3.94	5.69	0.44	4.81
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	117.97	12.30	27.96	27.40	9.50	5.59	6.15	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	100.25	12.81	23.85	21.64	15.90	5.74	5.74	0.00	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	126.90	8.49	36.26	36.26	20.83	8.49	4.63	0.39	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	118.49	13.67	24.81	25.32	7.60	7.60	7.60	1.01	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	102.85	13.46	28.84	28.84	24.03	6.25	4.81	0.48	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	116.48	9.54	23.06	29.42	16.70	5.96	5.96	0.00	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	126.99	10.94	24.30	28.56	14.58	5.47	6.08	0.00	3.65
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	79.55	11.76	17.29	24.21	14.53	1.38	8.30	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	106.40	11.02	30.40	26.60	13.30	7.60	6.84	0.38	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	92.44	14.98	22.72	22.72	8.78	5.68	7.23	0.00	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	84.05	10.28	19.95	26.00	20.56	1.81	12.09	0.60	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	106.16	10.77	31.69	23.45	17.11	5.70	6.02	0.63	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	97.02	5.33	22.92	19.19	11.19	2.67	3.73	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	78.73	8.62	21.26	20.69	13.22	1.15	6.32	0.00	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	95.65	9.26	25.20	26.23	19.03	5.14	7.20	1.03	5.14
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	99.03	15.56	21.93	20.51	7.78	4.24	7.07	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	81.72	10.21	24.97	26.10	15.32	0.00	3.97	0.00	3.40
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	106.50	7.49	27.46	29.54	12.90	5.41	6.66	0.00	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	105.71	8.61	25.06	14.88	10.18	3.13	3.92	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	81.00	9.19	17.54	23.38	15.45	1.67	7.52	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	85.49	7.90	28.81	22.77	13.01	2.79	5.58	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	74.26	10.04	20.07	21.41	8.03	2.68	2.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	94.63	11.76	21.92	25.13	11.23	1.07	5.35	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	81.63	10.10	30.71	20.61	9.29	4.04	5.66	0.81	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	70.67	11.01	17.44	16.52	4.59	0.00	6.42	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	85.35	10.67	19.56	26.67	8.89	2.67	8.89	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	79.78	13.68	24.50	21.09	10.26	1.71	3.99	1.14	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	71.32	10.74	26.84	14.57	7.67	0.77	4.60	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	104.51	8.75	27.91	21.34	8.75	1.64	8.75	1.09	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	81.96	8.91	24.50	21.38	10.69	0.89	4.45	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	77.99	11.70	26.78	22.88	10.14	0.78	7.02	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	88.19	18.57	23.21	25.20	11.94	1.33	4.64	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	89.38	16.63	20.79	12.47	16.63	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	106.66	12.54	27.58	4.33	8.43	6.15	1.60	0.46	0.91
Macrophage - monocyte derived, donor2	11313-117C8	69.18	9.54	13.95	3.67	5.32	2.57	1.10	0.73	0.92
Macrophage - monocyte derived, donor3	11389-118C3	106.83	15.34	29.76	4.72	8.00	4.85	1.57	0.39	1.31
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	58.41	14.34	18.05	5.84	3.72	7.97	1.59	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	87.15	14.10	35.02	4.28	6.81	1.11	1.11	0.32	0.95
Mallassez-derived cells, donor3	11930-125I4	84.37	15.71	25.16	6.81	5.98	1.25	0.69	0.97	0.14
Mammary Epithelial Cell, donor1	11273-116H4	124.55	25.81	46.73	6.18	17.54	5.98	1.69	1.00	2.49
Mammary Epithelial Cell, donor2	11350-117G9	103.95	15.93	22.87	3.19	5.21	0.87	0.87	0.58	2.03
Mammary Epithelial Cell, donor3	11422-118F9	49.89	7.23	6.73	2.99	4.49	2.49	1.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	88.81	96.94	40.68	2.71	12.20	2.71	1.36	4.07	2.71
Mast cell, donor1	11563-120D6	75.91	33.74	11.25	7.35	7.14	1.84	3.03	1.19	0.54
Mast cell, donor2	11565-120D8	119.46	43.39	16.94	6.24	9.51	0.59	2.67	1.49	0.00
Mast cell, donor3	11566-120D9	109.19	46.83	15.76	6.98	7.88	0.68	2.25	2.93	0.45
Mast cell, donor4	11567-120E1	110.27	34.04	15.07	7.27	6.91	1.42	3.01	3.19	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	84.72	37.59	10.65	4.77	3.11	1.11	2.22	2.11	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	125.49	39.11	12.26	4.67	5.84	1.75	2.33	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	60.92	20.88	8.26	4.93	2.64	1.15	1.95	0.46	0.11
Mast cell, expanded, donor8	11941-126A6	77.83	18.91	10.54	6.03	4.52	0.50	1.84	0.33	0.33
Melanocyte - dark, donor1	11502-119F8	88.06	13.33	22.09	8.95	13.53	2.29	2.39	1.09	0.60
Melanocyte - dark, donor2	11582-120F7	59.53	6.23	11.07	5.88	7.27	3.81	2.08	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	48.32	20.94	16.37	3.33	10.43	1.09	0.65	1.23	0.58
Melanocyte - light, donor1	11274-116H5	27.74	7.76	6.11	1.41	2.82	0.24	0.47	0.00	0.24
Melanocyte - light, donor2	11351-117H1	14.33	6.82	4.09	0.68	2.05	0.00	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	20.81	6.07	6.07	0.87	3.47	1.73	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	48.52	11.56	15.83	2.29	6.66	2.71	0.42	0.42	1.25
Melanocyte, donor2 (MC+2)	12739-135I3	40.34	11.03	9.14	1.61	8.88	2.96	0.54	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	51.96	24.91	13.93	4.82	10.18	3.48	1.07	1.07	0.54
Meningeal Cells, donor1	11493-119E8	108.55	17.62	26.55	14.39	10.17	0.25	3.35	0.62	0.50
Meningeal Cells, donor2	11573-120E7	83.19	22.89	18.05	10.12	13.20	1.32	3.52	0.44	2.20
Meningeal Cells, donor3	11654-122E7	149.07	18.75	40.42	15.81	9.94	3.18	3.26	0.65	1.30
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	82.70	10.84	22.81	7.41	7.70	4.28	1.43	0.29	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	54.84	13.48	26.37	8.45	9.46	4.23	1.91	0.91	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	34.17	2.63	5.26	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	3.92	3.92	1.31	2.62	2.62	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	106.21	8.61	21.53	3.59	8.61	5.02	2.15	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	53.15	15.46	15.04	5.51	6.35	1.91	1.69	0.85	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	59.81	7.04	15.08	2.01	5.03	7.04	0.50	1.01	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	60.21	6.81	14.94	2.20	3.52	1.10	0.66	0.22	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	53.33	4.38	9.50	2.19	2.92	2.92	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	54.02	6.55	9.00	3.89	5.12	0.82	1.23	0.20	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	66.21	8.03	7.48	3.74	7.06	0.28	2.35	0.14	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	30.11	5.20	9.29	3.35	2.60	0.74	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	103.42	12.89	28.68	9.21	10.13	3.29	2.37	0.13	1.05
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	25.82	4.75	6.83	2.67	2.97	0.00	0.30	0.89	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	35.03	4.67	2.34	2.34	4.67	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	53.15	5.76	11.53	3.84	7.04	0.00	0.64	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	103.50	11.34	30.13	5.67	10.99	3.19	3.90	0.35	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	78.81	10.95	28.15	9.38	15.01	4.69	1.88	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	88.53	11.61	13.79	8.71	8.71	5.81	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	58.07	13.52	24.13	3.18	10.34	5.57	1.33	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	33.03	11.51	7.51	2.00	6.01	1.00	1.50	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	67.64	13.66	26.95	2.46	9.68	7.80	1.01	0.14	1.52
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	135.03	109.38	48.61	1.35	20.25	0.00	0.00	4.05	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	116.00	22.90	24.38	6.16	8.37	7.39	2.96	1.48	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	88.93	17.67	17.37	6.48	6.77	4.42	1.47	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	89.88	55.31	24.20	0.00	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	86.48	17.67	21.08	5.58	4.96	3.72	2.48	0.93	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	64.30	12.86	17.01	3.94	5.39	3.11	1.24	0.21	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	81.06	83.38	23.16	6.95	16.21	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	103.86	17.77	23.77	7.01	8.01	5.76	2.00	1.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	95.89	21.41	15.83	6.98	7.91	2.79	0.47	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	214.13	58.40	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	87.99	18.90	18.90	5.08	8.54	4.67	3.05	0.41	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	89.49	13.46	19.01	3.17	3.96	3.56	1.98	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	179.58	0.00	0.00	8.55	0.00	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	67.26	9.73	11.50	6.19	5.31	4.42	0.88	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	77.13	13.68	14.44	2.66	6.84	6.46	1.14	1.52	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	115.80	65.80	44.74	5.26	10.53	1.32	2.63	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	79.80	14.43	15.92	5.09	7.43	2.97	1.91	1.06	1.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	58.01	22.10	16.57	2.76	7.37	0.00	0.00	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	105.81	21.46	21.76	7.15	10.43	6.56	2.68	0.00	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	65.39	53.65	26.83	1.68	8.38	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	373.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	99.11	18.57	21.08	3.01	8.28	8.03	1.25	0.50	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	70.59	13.55	15.21	4.75	4.04	4.04	0.95	1.19	2.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	126.06	65.24	53.63	6.63	16.59	4.98	2.21	3.87	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	104.30	16.35	36.15	8.29	5.30	9.44	0.46	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	80.56	12.41	22.30	5.05	6.31	4.00	2.10	0.42	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	99.47	14.88	33.84	4.08	6.93	2.04	1.02	0.61	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	95.47	12.66	29.61	8.58	6.22	6.22	0.64	0.86	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	84.47	17.12	22.67	4.22	5.11	1.33	1.33	1.56	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	61.91	113.50	10.32	0.00	10.32	0.00	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	113.01	18.62	39.86	7.01	9.42	7.67	1.53	0.44	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	89.22	25.85	25.35	3.55	10.65	0.00	0.51	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	132.56	72.91	39.77	3.31	19.88	0.00	0.00	8.28	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	128.29	24.19	45.39	5.16	10.87	4.62	1.36	1.90	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	107.34	20.29	21.17	5.88	6.76	1.76	1.18	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	123.21	67.60	41.43	3.27	9.81	1.09	2.18	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	106.20	16.34	35.08	9.13	10.09	6.25	0.96	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	117.27	15.61	22.01	3.60	4.40	8.81	2.00	0.40	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	109.70	83.64	30.17	1.37	12.34	2.74	2.74	4.11	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	113.13	18.02	35.04	9.01	9.01	4.00	1.00	3.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	61.16	97.85	28.54	4.08	12.23	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	119.55	31.53	35.91	5.26	3.94	9.63	3.07	2.19	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	94.91	64.01	35.32	3.31	12.14	3.31	2.21	5.52	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	90.29	64.68	43.55	1.92	12.17	1.28	0.00	6.40	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	114.79	24.54	39.91	10.66	7.19	10.91	1.24	0.99	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	100.21	48.71	35.49	2.09	5.57	1.39	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	117.12	132.59	24.31	4.42	4.42	0.00	2.21	8.84	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	87.18	19.83	23.93	8.55	5.13	7.86	1.71	1.37	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	126.03	35.01	32.82	1.31	5.69	0.88	1.75	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	78.83	74.57	29.12	3.55	6.75	1.07	0.71	3.55	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	93.70	26.93	25.25	8.42	5.61	9.82	1.68	0.84	2.24
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	124.27	25.77	22.44	6.23	5.82	2.49	1.66	2.08	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	74.01	61.77	25.06	2.33	6.99	2.91	0.58	4.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	101.66	20.81	28.36	7.54	6.64	6.33	0.90	1.21	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	116.87	17.11	25.04	5.84	5.84	6.68	2.09	2.09	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	115.50	14.44	0.00	0.00	0.00	0.00	14.44	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	96.05	28.63	29.55	3.69	9.24	3.69	3.69	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	124.64	23.33	22.20	5.69	3.41	2.85	1.71	0.57	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	69.37	31.64	20.31	4.28	6.22	0.83	1.11	2.21	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	76.97	18.92	22.55	6.22	5.44	3.63	1.30	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	105.10	24.45	24.45	4.29	7.72	1.29	0.86	2.14	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	70.51	49.54	22.23	1.27	2.54	0.00	1.91	2.54	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	88.07	23.75	23.49	4.27	5.07	2.94	0.53	0.27	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	99.08	23.35	17.06	6.59	3.89	3.89	1.50	0.90	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	64.55	28.39	15.68	3.53	5.79	0.28	0.85	0.57	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	88.87	16.56	21.66	5.73	2.87	6.05	0.64	0.32	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	99.51	21.45	20.57	3.98	3.76	1.99	0.88	1.33	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	81.53	31.47	18.96	2.65	3.79	0.00	0.76	3.03	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	85.52	17.61	19.04	4.55	3.98	3.41	1.14	0.57	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	90.95	14.50	13.52	4.42	3.44	3.69	2.95	0.74	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	71.03	43.66	21.51	5.87	7.17	0.00	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	88.21	20.88	15.00	5.88	2.94	4.70	2.94	1.18	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	86.79	19.61	17.30	5.48	5.77	4.04	2.31	2.02	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	90.26	42.04	17.31	7.42	4.12	2.47	1.24	2.89	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	92.01	24.72	19.95	6.85	5.06	4.76	3.28	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	79.10	3.77	11.30	0.00	3.77	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	58.81	7.13	14.26	1.78	8.91	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	103.17	20.04	26.29	5.59	7.89	6.90	0.99	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	75.74	16.83	16.83	4.21	3.16	6.31	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	97.26	13.44	17.59	4.35	7.51	6.52	1.78	0.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	137.84	13.97	32.60	8.38	14.90	6.52	3.73	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	115.66	23.28	33.80	6.01	15.40	10.14	0.38	1.50	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	75.11	11.45	14.65	4.26	6.39	4.53	1.07	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	86.07	17.19	19.68	3.73	4.41	2.26	0.45	0.23	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	72.20	16.21	22.84	1.47	7.37	3.68	1.47	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	92.71	17.22	26.02	2.93	9.16	4.40	1.10	1.10	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	90.22	24.89	31.11	1.56	6.22	14.00	0.00	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	63.06	12.83	11.76	4.81	1.60	1.07	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	57.96	11.59	15.46	0.00	11.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	64.64	13.13	23.23	4.04	9.09	10.10	0.00	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	64.51	9.70	11.81	2.95	4.64	5.06	0.42	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	21.79	14.98	6.81	4.09	0.00	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	24.80	7.63	6.99	5.72	4.45	0.00	0.64	1.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	19.44	12.15	2.43	0.00	2.43	0.00	0.81	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	28.70	6.04	7.55	3.02	1.51	0.00	3.02	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	39.97	11.42	5.71	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	65.25	35.89	32.62	9.79	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	99.80	23.76	23.76	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	25.10	50.20	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	53.43	15.08	21.33	3.45	7.32	2.80	1.51	1.08	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	42.33	9.41	12.54	4.70	6.27	4.18	1.05	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	39.38	10.01	12.01	2.00	2.67	1.33	1.33	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	23.37	7.93	11.69	0.42	3.76	1.67	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	30.80	12.17	8.56	4.75	8.37	1.52	0.95	0.76	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	54.26	90.96	22.34	3.19	22.34	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	20.40	6.12	6.12	2.04	2.04	1.36	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	84.53	33.08	47.78	11.03	12.86	3.68	1.84	1.84	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	30.97	5.02	9.21	2.51	5.02	0.84	0.42	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.96	7.44	10.46	1.63	1.86	0.46	0.46	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	33.51	8.38	6.76	2.97	4.86	0.81	0.27	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	53.61	17.87	8.83	4.41	5.26	1.26	1.26	1.68	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	22.27	55.67	55.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	35.74	5.46	13.40	3.47	3.97	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	28.15	8.93	10.83	3.25	6.23	1.35	1.08	0.81	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	41.48	4.99	16.09	0.91	5.89	0.91	0.91	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	41.32	8.65	15.35	3.10	5.06	0.65	1.31	0.65	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	57.05	14.58	14.76	5.83	11.85	2.00	1.28	0.91	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	44.03	6.90	13.26	2.12	4.77	2.12	0.00	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	44.42	6.00	15.61	1.20	2.40	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	35.44	10.17	11.16	7.55	5.58	1.64	1.64	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	33.50	4.55	15.45	1.79	7.97	0.81	0.33	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	73.55	23.11	27.87	9.52	14.82	1.41	1.41	1.06	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	30.24	5.63	14.77	0.70	4.22	1.41	0.70	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	45.51	5.52	23.45	3.68	8.73	1.38	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	49.17	5.14	19.60	2.57	9.00	1.29	1.93	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	32.76	10.69	12.76	9.66	12.07	1.03	1.03	0.00	3.79
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	131.48	37.93	55.63	50.57	32.87	0.00	5.06	0.00	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	87.55	22.72	29.85	7.13	16.26	2.01	2.23	1.34	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	50.81	7.62	22.44	6.77	7.20	2.96	0.00	0.85	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	39.40	5.70	10.21	3.32	7.12	2.14	1.42	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	59.24	9.01	16.74	3.86	8.58	0.43	1.29	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	54.17	72.22	63.19	27.08	9.03	0.00	0.00	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	30.32	5.33	14.33	3.33	7.00	0.67	0.67	1.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	75.29	24.80	35.62	7.66	17.13	2.25	1.80	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	51.58	10.32	23.01	6.75	4.36	3.57	0.40	1.19	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	52.93	5.57	17.64	3.71	5.57	1.86	1.86	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	38.59	9.46	16.65	5.30	6.43	0.76	0.76	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	38.13	8.47	16.95	2.93	7.50	0.98	0.33	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	31.38	6.97	6.54	0.44	3.92	0.44	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	72.82	20.81	32.56	8.59	22.61	0.45	1.36	2.26	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	43.21	14.99	28.22	6.17	3.53	2.65	3.53	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	55.85	4.65	15.96	5.98	6.65	1.99	1.33	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	40.18	7.44	16.87	1.49	2.98	0.99	0.99	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	33.31	4.59	15.70	2.30	7.66	0.77	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	45.67	7.86	9.68	2.42	5.14	1.21	3.33	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	76.25	16.13	24.09	7.74	14.59	1.55	1.11	0.88	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	52.86	10.16	29.14	4.07	10.84	0.68	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	117.52	61.31	81.75	45.99	20.44	0.00	10.22	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	46.34	4.27	17.07	3.05	4.27	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	29.90	6.29	14.16	2.83	6.29	1.26	0.94	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	35.11	8.47	10.90	3.03	5.45	0.30	0.91	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	56.17	9.49	22.15	3.16	5.54	1.58	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	36.28	14.74	12.47	17.00	3.40	3.40	1.13	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	40.46	40.46	25.29	30.35	20.23	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	44.97	9.07	23.73	3.11	8.45	5.22	0.99	0.62	0.37
Myoblast, donor2	11322-117D8	69.81	10.36	18.80	3.84	6.90	4.41	0.58	0.96	1.15
Myoblast, donor3	11398-118D3	60.54	12.95	22.37	8.24	8.58	2.19	1.18	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	76.76	37.21	19.12	14.45	11.67	4.96	2.48	1.17	1.90
Natural Killer Cells, donor1	11230-116C6	125.77	88.87	37.21	16.30	19.07	4.61	6.15	2.77	0.92
Natural Killer Cells, donor2	11311-117C6	130.27	78.71	36.49	13.57	15.08	13.27	4.52	2.41	3.32
Natural Killer Cells, donor3	11387-118C1	111.90	76.20	29.45	15.64	12.88	11.96	3.13	2.76	2.94
Neural stem cells, donor1	11275-116H6	75.13	71.86	19.60	10.16	4.72	0.36	5.81	1.81	0.73
Neural stem cells, donor2	11352-117H2	48.14	53.92	21.18	11.55	1.93	0.00	1.93	3.85	0.00
Neurons, donor1	11494-119E9	51.21	50.07	9.10	15.93	1.14	3.41	1.14	2.28	0.00
Neurons, donor2	11574-120E8	32.14	22.46	6.38	7.71	6.16	0.66	2.86	1.32	1.10
Neurons, donor3	11655-122E8	39.46	39.46	3.29	8.22	2.47	4.11	0.82	3.29	0.82
Neutrophils, donor1	11233-116C9	283.04	21.34	57.54	8.35	5.57	6.50	2.78	0.93	9.28
Neutrophils, donor2	11314-117C9	211.62	26.09	52.18	2.90	5.80	8.70	0.00	0.00	11.60
Neutrophils, donor3	11390-118C4	359.79	23.82	54.36	15.88	5.50	1.83	2.44	0.61	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	80.15	9.97	20.07	7.96	11.16	1.90	3.44	0.59	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	78.47	10.09	11.72	5.86	7.49	7.16	0.65	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	64.18	19.25	15.24	7.22	9.02	2.41	3.01	0.60	0.40
Olfactory epithelial cells, donor1	11933-125I7	54.65	11.70	12.25	3.30	8.53	3.30	1.65	0.83	0.69
Olfactory epithelial cells, donor2	11934-125I8	68.90	13.75	25.04	4.63	15.20	7.82	1.88	0.58	5.21
Olfactory epithelial cells, donor3	11935-125I9	68.33	10.67	22.36	5.22	12.15	3.41	0.79	0.11	1.25
Olfactory epithelial cells, donor4	11936-126A1	77.43	11.98	20.36	4.87	11.30	2.24	2.05	0.39	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	114.95	16.85	36.71	9.63	10.23	3.61	1.81	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	62.11	9.57	13.40	5.53	8.93	0.64	0.85	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	16.00	2.29	10.29	2.29	5.72	12.57	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	58.97	10.55	9.93	6.21	12.41	1.86	2.48	0.00	0.00
Osteoblast, donor1	11277-116H8	27.36	3.91	6.64	3.13	3.91	0.98	0.78	0.20	0.00
Osteoblast, donor2	11354-117H4	95.52	21.77	25.28	4.92	4.21	4.21	0.00	1.40	0.70
Osteoblast, donor3	11426-118G4	75.36	11.20	27.02	6.40	10.49	1.60	1.42	0.36	0.36
Pancreatic stromal cells, donor1	11249-116E7	93.50	14.40	27.88	6.15	11.29	5.14	2.11	0.51	0.93
Pericytes, donor1	11491-119E6	25.03	4.34	5.01	3.67	5.34	0.11	1.00	0.00	0.11
Pericytes, donor2	11571-120E5	39.39	8.60	8.38	6.56	5.89	0.45	1.13	0.00	0.45
Pericytes, donor3	11652-122E5	71.61	8.75	37.03	7.73	15.06	4.27	1.22	0.41	0.41
Perineurial Cells, donor1	11499-119F5	104.21	11.19	25.43	10.96	13.56	3.96	1.70	0.57	1.02
Perineurial Cells, donor2	11579-120F4	71.86	9.75	13.62	6.72	9.20	0.74	1.66	0.64	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	194.75	79.05	28.37	14.98	8.92	4.46	5.74	1.59	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	136.14	37.46	20.08	15.18	12.00	12.49	4.41	1.22	3.18
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	170.57	53.19	40.25	16.69	12.81	4.27	2.59	1.94	0.91
Placental Epithelial Cells, donor1	11278-116H9	49.99	11.00	17.22	3.11	3.59	1.43	0.96	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	60.99	14.42	13.31	4.44	0.00	0.00	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	68.32	7.46	20.03	7.85	5.50	1.77	2.16	0.79	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	28.80	6.96	7.91	2.22	2.53	0.95	0.63	0.32	2.22
Preadipocyte - breast, donor1	11467-119B9	47.27	10.13	12.57	2.63	1.88	2.63	1.69	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	42.94	4.70	16.32	0.91	5.74	1.44	0.52	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	54.94	10.81	12.38	4.95	6.08	3.38	0.90	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	62.66	12.79	17.05	2.98	3.84	2.24	1.39	0.64	0.53
Preadipocyte - omental, donor2	11329-117E6	53.69	11.35	14.40	4.36	7.86	2.62	0.44	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	67.04	17.48	23.21	4.58	6.02	5.59	1.43	0.72	0.86
Preadipocyte - perirenal, donor1	11469-119C2	32.48	10.83	5.91	0.98	5.91	0.98	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	39.00	5.84	11.98	1.23	4.91	0.00	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	131.21	19.12	31.70	6.91	8.50	7.44	2.48	0.35	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	68.45	12.26	24.01	3.58	6.30	3.07	1.19	0.85	0.51
Preadipocyte - visceral, donor1	11280-116I2	96.97	20.40	21.14	5.12	7.64	2.24	2.33	0.93	1.02
Preadipocyte - visceral, donor2	11357-117H7	109.52	19.33	22.09	5.06	6.90	2.76	1.84	0.46	2.76
Preadipocyte - visceral, donor3	11429-118G7	65.83	12.43	15.05	3.55	5.12	3.55	1.78	1.25	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	93.23	24.14	43.29	13.58	11.92	3.92	1.66	0.91	2.11
Prostate Epithelial Cells, donor2	11331-117E8	54.44	13.27	19.36	1.62	8.67	3.66	0.81	0.27	1.08
Prostate Epithelial Cells, donor3	11404-118D9	129.70	16.53	22.96	7.65	10.35	4.72	1.96	0.55	2.82
Prostate Stromal Cells, donor1	11254-116F3	70.39	9.80	30.53	4.78	10.71	3.30	1.37	0.46	0.80
Prostate Stromal Cells, donor2	11332-117E9	106.86	13.45	30.66	6.45	12.73	8.07	2.51	0.54	2.69
Prostate Stromal Cells, donor3	11405-118E1	67.05	11.68	26.80	4.07	10.64	10.11	1.36	0.73	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	59.13	9.85	16.06	4.01	6.20	0.00	1.09	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	91.21	13.86	23.43	10.26	9.01	2.43	1.52	0.28	0.83
Renal Epithelial Cells, donor1	11517-119H5	40.58	7.10	9.64	4.57	3.55	0.00	1.52	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	40.55	10.67	7.82	4.27	6.40	2.85	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	103.43	18.63	18.53	8.47	9.10	2.33	2.75	0.53	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	34.72	5.45	6.13	2.04	3.40	0.00	0.68	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	61.18	8.89	11.59	2.70	6.33	1.08	1.08	0.40	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	99.90	15.98	30.19	6.44	12.65	4.88	0.67	0.44	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	31.28	1.33	6.65	2.66	3.33	1.33	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	41.16	4.40	9.90	5.72	3.08	0.44	1.76	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	40.75	5.02	8.15	2.51	6.27	5.64	1.88	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	26.35	2.77	5.27	3.61	4.72	0.28	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	97.71	19.59	19.59	11.27	8.05	2.15	2.42	0.81	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	62.41	13.07	16.02	6.75	2.53	5.06	0.42	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	46.28	9.26	16.01	6.17	6.17	2.70	1.35	0.19	1.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	66.64	11.93	16.85	12.70	6.22	6.48	3.37	0.78	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	55.14	8.24	11.37	10.52	9.95	0.57	1.14	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	26.76	5.15	7.20	5.15	1.03	2.06	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	81.80	24.34	16.06	7.53	7.28	0.75	2.01	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	93.55	27.93	19.78	10.16	5.61	0.80	4.14	1.47	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	63.43	7.15	12.51	2.68	0.89	5.36	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	84.21	9.36	13.21	13.21	3.30	2.20	1.10	1.10	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	91.07	32.48	13.92	13.92	4.64	0.00	2.90	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	74.89	18.20	12.35	8.71	9.88	0.39	2.08	0.65	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	75.77	18.17	20.75	8.34	7.85	1.99	1.99	1.09	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	84.21	15.84	17.07	10.26	5.80	2.23	2.57	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	98.37	17.74	12.40	13.77	9.68	1.36	2.85	0.74	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	79.02	16.90	19.70	5.13	9.09	3.96	2.68	0.23	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	74.42	18.03	16.64	8.78	8.55	2.31	0.69	0.69	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	84.61	18.48	11.36	9.17	9.99	0.14	2.46	0.55	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	80.33	15.13	15.73	7.26	8.47	1.21	1.82	0.76	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	87.09	16.66	18.28	9.14	5.55	0.72	1.61	0.18	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	86.93	15.49	15.92	9.90	8.03	0.57	3.30	0.86	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	78.77	16.20	15.56	6.22	6.76	2.90	2.15	0.21	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	71.91	15.71	15.71	8.41	5.53	4.43	1.33	0.22	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	105.15	20.84	15.68	10.71	13.38	0.76	2.68	1.15	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	82.26	16.77	20.59	7.08	8.38	1.96	2.24	0.84	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	104.29	16.16	19.73	9.77	4.13	0.38	4.32	0.75	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	88.52	23.75	16.59	12.34	9.69	0.13	2.39	1.59	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	80.60	21.42	20.93	9.15	8.96	2.14	3.41	0.58	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	93.95	19.29	15.85	10.50	5.92	2.86	2.86	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	89.17	18.37	14.74	11.21	10.57	0.53	3.10	0.85	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	79.05	16.82	16.54	8.13	9.25	2.80	2.80	0.56	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	81.69	18.12	23.58	6.49	5.98	1.71	1.88	0.85	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	90.80	22.61	15.32	11.30	11.30	0.18	3.28	0.36	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	77.14	16.56	16.92	6.25	7.48	2.70	2.94	0.25	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	72.13	16.39	20.15	9.27	6.58	2.55	2.01	1.07	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	97.65	19.58	12.27	8.49	11.56	1.65	2.36	0.94	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	74.01	19.25	18.06	9.72	8.73	2.58	2.38	0.99	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	82.31	20.58	21.05	9.59	7.25	2.34	1.87	0.70	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	86.26	16.59	19.49	8.92	9.95	0.41	1.45	1.45	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	72.11	27.21	13.27	7.30	4.87	0.66	2.21	0.22	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	83.34	21.31	25.07	8.56	9.40	1.67	2.51	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	101.75	21.67	16.96	12.11	13.32	0.27	3.90	1.08	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	89.58	27.76	20.44	10.90	13.28	0.51	3.75	1.36	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	97.75	22.94	26.61	5.78	9.64	1.93	2.51	1.16	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	100.93	19.77	19.26	7.39	12.72	0.52	3.78	0.86	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	89.98	26.61	24.55	7.82	9.19	1.10	1.92	0.96	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	81.76	19.86	20.36	7.39	9.85	1.81	1.97	0.33	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	86.41	16.02	15.51	9.88	10.06	0.51	1.70	0.51	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	80.78	20.57	19.38	10.80	9.03	2.66	3.11	0.74	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	90.09	21.32	18.66	9.06	7.46	1.07	0.80	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	79.50	18.94	7.88	13.55	9.40	0.41	3.73	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	67.38	18.57	12.62	8.33	7.86	2.86	1.19	0.24	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	118.30	28.22	19.75	12.09	10.48	1.01	3.22	1.61	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	65.17	20.25	7.44	12.15	7.63	0.75	4.80	0.09	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	94.33	23.41	14.67	21.31	9.78	2.10	3.14	0.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	85.83	25.08	18.13	10.28	9.67	1.21	4.23	2.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	73.31	16.40	5.26	9.91	6.61	0.61	3.30	0.61	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	110.91	36.10	20.09	14.12	8.59	1.46	3.49	1.60	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	62.06	15.21	11.56	7.30	9.13	1.83	3.04	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	79.27	18.39	4.52	8.14	8.44	0.60	3.32	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	83.92	19.00	11.54	11.99	9.27	2.49	3.17	0.68	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	98.25	17.97	12.58	8.39	6.59	3.59	2.40	1.50	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	63.05	19.48	7.32	6.38	6.97	0.12	2.95	0.47	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	61.47	19.00	11.95	9.39	5.12	1.49	2.13	0.43	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	77.53	18.03	12.62	13.22	7.81	3.61	3.00	0.00	0.60
Schwann Cells, donor1	11498-119F4	45.70	8.28	7.33	4.14	3.76	0.19	1.32	0.56	1.32
Schwann Cells, donor2	11578-120F3	78.26	13.61	27.22	10.21	10.21	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	65.29	14.02	13.80	7.67	9.86	8.98	1.75	0.88	2.19
Sebocyte, donor1	11220-116B5	93.12	13.15	46.01	5.48	13.15	1.10	0.00	0.55	0.55
Sebocyte, donor2	11301-117B5	56.53	8.27	20.68	3.68	8.73	2.30	0.92	0.92	1.38
Sebocyte, donor3	11378-118B1	57.92	3.09	17.11	5.36	4.95	1.65	0.41	0.21	0.41
Sertoli Cells, donor1	11255-116F4	76.20	18.22	29.82	8.28	4.97	8.28	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	64.96	14.12	19.77	2.82	5.65	11.30	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	92.11	29.56	24.46	8.27	15.04	2.73	4.57	0.79	0.62
Skeletal Muscle Cells, donor2	11358-117H8	38.31	4.34	9.40	12.29	12.29	1.45	2.17	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	43.47	6.69	9.20	3.34	4.18	0.00	0.84	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	81.22	13.82	17.59	6.28	6.91	2.20	2.04	0.63	1.41
Skeletal Muscle Cells, donor5	11455-119A6	81.01	14.72	17.84	5.20	7.28	2.68	2.97	0.59	1.04
Skeletal Muscle Cells, donor6	11459-119B1	135.74	18.01	31.70	10.47	15.70	4.16	4.16	0.92	1.69
Skeletal Muscle Satellite Cells, donor1	11240-116D7	83.79	11.72	13.99	7.06	6.80	2.65	3.65	0.00	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	91.89	9.70	16.98	8.28	7.85	5.56	2.00	0.86	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	131.35	17.66	40.58	17.26	13.19	6.55	2.98	0.89	1.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	116.86	19.71	38.50	17.95	18.28	4.13	4.30	0.59	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	49.22	13.75	16.65	3.62	10.13	2.90	0.00	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	23.67	6.33	4.40	1.93	4.13	0.96	0.96	0.96	0.28
Skin - palm, donor1	10286-104F7	29.55	64.47	13.43	0.00	0.00	5.37	0.00	8.06	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	60.55	4.90	19.03	3.32	3.89	1.44	0.72	0.43	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	87.51	5.73	16.36	3.27	5.73	1.64	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	64.65	5.58	18.18	6.23	4.67	0.65	0.65	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	87.85	20.99	27.11	4.59	9.31	2.36	1.95	0.70	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	99.44	23.35	34.88	5.49	17.58	7.31	1.69	1.27	1.83
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	123.27	6.34	26.43	5.92	6.77	3.17	1.48	0.00	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	127.87	35.00	35.60	7.05	13.72	3.82	3.15	1.35	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	67.27	8.33	16.05	2.16	16.35	0.62	2.16	1.23	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	42.91	5.78	12.01	1.11	5.34	0.22	0.44	0.22	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	51.14	10.58	28.22	5.88	13.52	1.18	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	35.80	7.29	10.83	1.77	3.76	0.44	0.22	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	45.28	3.94	18.90	0.39	5.51	0.79	0.00	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	69.53	14.68	23.95	6.18	9.27	0.77	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	56.04	13.01	5.00	6.00	7.01	3.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	37.00	5.59	14.11	3.19	6.39	0.80	0.93	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	55.64	10.64	16.18	3.32	5.10	4.21	1.11	0.44	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	53.52	18.69	16.52	4.35	11.39	0.90	1.02	0.13	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	63.49	12.05	31.58	7.16	15.30	5.54	3.58	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	65.86	12.99	30.71	5.91	13.29	3.84	1.48	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	134.53	5.55	74.03	21.50	23.63	7.26	2.42	0.71	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	49.13	4.55	17.57	5.37	7.16	0.65	0.98	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	96.20	17.05	21.92	3.35	13.09	3.35	1.22	1.22	1.83
Smooth Muscle Cells - Carotid, donor1	11285-116I7	31.07	5.30	5.81	3.28	2.78	0.51	1.01	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	6.12	6.12	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	22.41	4.29	3.81	1.43	0.95	0.48	1.43	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	94.53	7.52	49.70	7.96	9.73	4.72	1.47	0.15	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	80.07	10.12	36.81	6.89	12.70	6.67	0.00	0.22	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	102.44	12.49	38.41	8.82	11.97	5.56	1.36	0.84	1.05
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	39.44	7.58	20.73	1.86	6.65	0.46	1.08	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	37.73	5.39	12.93	3.23	4.31	0.00	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	43.63	7.47	13.75	2.39	3.59	1.20	0.30	0.60	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	53.60	6.15	20.48	6.49	6.49	0.68	0.68	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	103.19	10.68	20.50	10.76	10.44	2.36	2.83	0.79	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	73.07	18.82	20.23	3.42	6.74	1.51	1.11	0.40	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	61.21	14.79	24.12	1.37	5.92	7.28	1.37	0.46	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	25.96	3.62	6.04	1.81	7.85	0.60	1.21	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	152.07	19.07	42.12	11.13	17.22	6.89	2.38	1.32	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	46.34	12.12	11.05	4.93	9.05	0.53	1.86	0.53	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	60.73	11.77	22.66	4.51	11.02	5.01	0.50	0.13	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	36.78	5.58	9.13	1.52	3.04	2.54	0.51	0.76	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	52.17	8.29	14.32	3.32	6.03	1.96	0.75	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	30.01	6.00	7.50	2.25	3.00	1.50	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	32.31	29.72	10.34	1.29	2.58	1.29	0.00	0.00	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	42.79	7.91	11.16	2.33	5.12	0.93	0.93	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	41.40	10.10	11.11	1.51	2.52	3.53	0.50	0.00	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	28.52	6.58	8.46	0.94	5.01	1.88	0.31	0.31	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	38.35	3.24	9.73	2.36	2.65	0.88	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	141.04	25.41	36.24	7.91	15.83	1.67	2.25	0.92	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	92.50	15.42	14.01	3.27	9.34	5.61	1.40	0.47	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	34.68	7.20	13.82	4.46	7.05	0.72	0.58	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	53.80	9.69	24.22	6.12	9.69	3.31	1.78	0.25	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	31.03	6.21	9.78	2.44	3.95	0.38	0.75	0.75	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	111.66	15.09	28.65	8.11	13.97	3.63	1.96	0.70	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	99.21	9.22	44.66	9.55	25.39	3.69	1.84	0.50	0.92
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	37.62	5.71	5.71	5.71	3.81	0.48	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	28.38	7.34	13.21	2.45	5.87	0.24	1.22	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	70.70	11.93	19.89	2.87	14.58	1.77	1.77	0.66	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.09	4.39	3.51	3.80	2.05	0.59	0.00	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	55.98	7.39	15.35	2.92	5.25	2.92	0.00	0.78	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	65.32	10.58	39.40	2.38	9.78	3.97	0.53	0.79	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	40.54	3.72	15.25	2.23	4.09	3.35	1.12	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	86.24	7.91	42.04	3.59	11.86	5.75	0.00	0.36	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	55.36	7.67	22.14	2.56	3.69	1.42	0.00	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	71.68	16.94	24.81	7.88	10.24	2.76	1.58	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	45.71	8.13	13.71	2.54	5.08	2.29	0.51	0.76	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	67.09	12.38	19.17	3.99	7.59	2.00	0.40	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	50.58	8.78	24.66	2.51	7.11	4.18	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	60.50	8.71	15.58	4.13	4.13	4.58	0.46	0.00	0.46
Synoviocyte, donor1	11291-117A4	101.16	14.81	29.12	3.03	8.25	3.20	2.02	0.50	0.17
Synoviocyte, donor2	11368-117I9	68.89	9.72	20.79	4.02	10.23	6.20	2.35	0.67	0.50
Synoviocyte, donor3	11440-118H9	53.62	8.49	11.17	2.23	6.03	1.56	0.89	0.22	1.79
Trabecular Meshwork Cells, donor1	11532-120A2	58.96	10.72	8.93	3.57	1.43	0.71	0.71	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	87.21	3.96	13.87	3.96	7.93	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	45.15	8.57	11.58	4.63	6.25	1.62	0.46	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	63.08	7.46	12.62	3.51	5.16	2.44	1.36	0.29	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	26.67	3.48	5.03	1.55	3.87	1.93	0.39	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	35.51	5.73	8.59	5.15	2.86	0.57	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	94.61	27.80	19.81	8.00	6.77	1.48	3.44	1.35	0.25
Urethra, donor2	10319-105A4	48.56	39.57	3.60	3.60	3.60	3.60	1.80	0.00	1.80
Urothelial Cells, donor1	11520-119H8	37.19	5.84	9.03	1.86	4.78	0.00	0.53	0.27	0.00
Urothelial Cells, donor2	11600-120H7	38.05	4.41	4.01	2.00	2.40	2.40	0.80	0.00	0.40
Urothelial Cells, donor3	11681-122H7	29.57	3.44	4.35	1.60	3.67	0.46	0.46	0.69	0.00
Urothelial cells, donor0	11216-116B1	113.23	12.26	13.82	6.02	8.25	4.01	2.01	0.67	2.01
Whole blood (ribopure), donor090309, donation1	12179-129A1	144.14	50.72	17.80	29.36	2.67	0.89	1.78	2.67	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	142.96	50.04	18.58	27.16	1.43	2.86	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	119.79	36.96	14.37	21.22	4.11	6.16	2.74	2.05	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	127.40	44.42	18.94	19.63	4.13	3.10	3.10	1.38	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	136.54	38.93	15.69	18.59	1.16	2.32	1.74	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	125.99	49.98	10.41	13.54	1.04	0.00	5.21	2.08	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	130.33	52.31	11.01	30.29	4.59	0.92	4.59	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	105.90	38.34	14.61	17.35	3.65	1.83	0.00	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	104.98	13.94	42.31	10.24	17.27	4.56	1.36	1.48	0.86
Wilms' tumor cell line:HFWT	10597-108E3	59.84	53.68	17.60	3.52	14.08	4.40	2.64	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	142.17	25.42	20.95	6.14	9.50	11.73	1.68	0.84	1.68
achilles tendon, donor2	10292-104G4	26.86	22.73	16.53	4.13	0.00	8.27	2.07	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	228.44	27.03	52.27	31.10	13.00	17.85	4.33	1.53	4.59
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	110.05	25.54	27.16	10.45	17.88	4.18	2.32	2.32	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	181.98	26.23	57.57	35.97	15.31	5.82	4.51	0.71	1.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	116.46	25.58	23.40	8.71	13.61	9.80	4.35	0.82	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	114.68	15.46	25.02	4.78	5.90	8.71	1.41	0.00	3.37
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	70.00	17.13	13.53	6.56	8.46	3.17	3.38	0.42	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	173.40	25.04	28.31	12.79	8.17	13.88	4.08	1.09	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	128.23	23.35	28.64	7.49	11.46	8.37	1.32	0.88	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	105.77	20.83	17.15	6.13	4.90	8.17	1.63	0.82	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	77.27	31.84	25.63	14.37	8.54	6.60	1.55	1.55	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	126.04	45.63	32.75	7.91	10.30	11.78	3.13	3.50	2.21
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	120.92	66.31	31.20	19.50	3.90	23.40	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	111.54	13.71	14.41	3.72	7.20	7.20	1.39	1.39	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	137.48	27.96	30.29	9.58	10.61	9.58	2.59	2.33	1.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	130.34	24.84	25.72	7.01	5.84	10.81	2.92	1.17	3.80
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	149.19	44.15	19.98	6.97	6.04	2.32	5.58	3.25	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	94.18	36.19	13.98	2.47	2.47	4.11	0.41	1.23	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	71.21	19.34	14.43	7.06	3.07	0.31	1.53	0.92	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	75.95	20.06	22.19	8.96	5.97	1.28	3.41	1.28	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	79.77	17.59	16.38	7.89	6.07	2.73	3.34	0.91	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	90.75	22.63	19.98	13.48	4.33	1.20	4.57	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	111.81	13.36	17.37	6.24	2.90	2.45	0.89	1.34	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	95.73	49.03	24.68	5.34	8.34	2.00	2.00	1.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	89.19	96.63	18.58	3.72	7.43	0.00	0.00	9.29	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	129.95	16.95	18.46	4.52	2.64	12.43	3.01	1.13	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	85.48	36.20	14.83	5.23	8.29	2.18	0.87	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	37.49	76.85	33.74	0.00	16.87	0.00	1.87	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	69.00	29.44	16.01	4.71	4.95	0.94	1.65	0.94	0.24
adipose tissue, adult, pool1	10010-101C1	141.00	31.33	19.86	8.84	8.07	0.93	4.81	1.40	0.47
adipose, donor1	10184-103D4	141.91	46.91	28.73	31.67	13.49	12.31	5.86	0.59	8.21
adipose, donor2	10185-103D5	49.47	12.17	8.52	13.79	4.06	6.89	2.43	0.41	0.41
adipose, donor3	10186-103D6	48.20	13.89	11.98	9.80	8.17	5.72	1.09	0.27	0.54
adipose, donor4	10187-103D7	59.81	10.40	10.40	10.40	6.93	7.80	0.87	0.87	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	72.60	7.89	6.63	5.84	3.95	1.42	2.05	0.95	0.16
adrenal gland, adult, pool1	10081-102A9	61.84	21.83	3.64	7.28	3.64	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	93.78	23.48	11.07	6.54	5.20	4.14	3.20	1.33	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	65.74	18.94	24.30	2.50	11.79	4.29	2.86	0.71	0.36
amniotic membrane cells, donor1	12235-129G3	85.32	14.84	16.69	6.26	5.56	3.01	2.32	0.23	0.93
amniotic membrane cells, donor2	12236-129G4	94.33	12.51	22.99	11.16	8.45	2.03	1.01	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	79.25	4.12	5.30	5.60	4.12	0.88	1.77	0.29	0.59
amygdala - adult, donor10196	10167-103B5	48.62	41.50	5.93	2.37	3.56	1.19	0.00	1.19	1.19
amygdala, adult, donor10252	10151-102I7	59.01	53.94	7.50	10.54	3.04	1.62	3.04	3.04	1.22
amygdala, newborn, donor10223	10360-105E9	38.73	31.63	13.23	4.52	3.55	3.23	0.65	0.97	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	73.47	32.72	17.83	19.10	14.26	4.33	4.71	1.53	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	116.93	36.40	36.40	10.15	9.49	11.25	3.09	1.76	2.21
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	34.74	44.09	9.02	6.68	11.36	6.35	3.34	3.01	0.33
aorta, adult, pool1	10052-101G7	82.57	20.59	10.00	6.28	7.06	1.96	3.53	1.96	1.96
appendix, adult	10189-103D9	157.58	46.19	46.19	32.99	10.48	4.27	5.43	2.33	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	43.34	37.83	5.50	6.19	4.13	2.75	4.82	1.72	1.38
artery, adult	10190-103E1	78.80	43.48	10.87	28.53	4.08	2.72	4.08	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	48.10	59.69	10.14	12.17	3.91	3.19	3.77	3.33	0.43
b cell line:RPMI1788	10427-106D4	243.87	52.05	40.60	48.18	22.60	14.57	12.19	2.83	3.27
basal cell carcinoma cell line:TE 354.T	10702-109G9	43.56	16.37	14.15	2.77	9.43	4.99	1.39	0.28	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	104.39	34.53	49.81	14.88	25.60	2.48	3.47	1.89	1.19
bile duct carcinoma cell line:TFK-1	10496-107C1	113.32	39.67	44.52	7.53	20.59	6.70	1.51	0.67	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	58.72	11.18	10.63	8.95	10.07	8.39	2.80	0.00	0.56
bladder, adult, pool1	10011-101C2	127.54	34.66	15.32	10.32	10.97	0.87	4.89	2.39	0.87
blood, adult, pool1	10053-101G8	104.09	44.29	22.15	33.22	4.43	4.43	6.64	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	45.39	21.41	27.40	2.57	10.28	1.71	0.00	1.71	0.00
bone marrow, adult	10192-103E3	101.90	20.24	12.15	2.70	3.37	0.67	2.02	0.67	2.70
brain, adult, donor1	10084-102B3	25.63	23.58	2.05	1.03	4.10	0.00	7.18	0.00	1.03
brain, adult, pool1	10012-101C3	43.10	35.19	7.57	6.90	3.79	1.00	2.78	2.00	0.89
brain, fetal, pool1	10085-102B4	32.06	29.39	0.00	2.67	8.01	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	175.09	52.20	75.32	25.11	44.60	8.59	9.58	1.65	2.64
breast carcinoma cell line:MDA-MB-453	10419-106C5	106.22	45.93	25.84	8.49	6.74	0.87	2.37	0.25	0.37
breast, adult, donor1	10080-102A8	101.02	17.05	6.94	11.36	3.16	1.26	5.68	2.53	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	125.64	36.46	15.37	6.10	6.61	6.73	2.29	1.40	1.65
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	37.72	31.23	4.95	3.71	4.95	3.40	1.24	1.24	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	94.39	8.29	5.30	10.59	3.22	8.06	3.91	0.00	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	114.51	20.09	33.17	5.57	18.88	14.77	2.66	0.00	1.69
carcinoid cell line:NCI-H1770	10703-109H1	46.08	17.40	3.76	8.46	4.70	5.64	1.88	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	65.52	36.64	23.74	10.94	13.78	0.98	1.75	1.86	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	79.54	18.38	8.24	5.70	5.70	7.61	1.90	0.32	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	62.29	44.72	10.38	9.32	9.32	3.73	3.99	1.86	2.13
caudate nucleus - adult, donor10196	10177-103C6	52.96	21.88	3.45	10.36	5.76	2.30	0.00	3.45	0.00
caudate nucleus, adult, donor10252	10164-103B2	38.65	40.33	7.53	8.70	3.51	1.84	1.34	1.00	1.17
caudate nucleus, adult, donor10258	10379-105H1	48.90	34.39	4.58	6.11	6.88	3.06	1.53	3.06	0.00
caudate nucleus, newborn, donor10223	10354-105E3	39.19	29.66	10.99	6.23	3.30	1.46	0.73	0.37	1.10
cerebellum - adult, donor10196	10173-103C2	49.53	17.48	0.00	14.57	5.83	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	47.19	32.88	4.48	14.31	2.14	0.64	3.63	2.35	1.28
cerebellum, adult, pool1	10083-102B2	14.83	18.63	1.72	5.52	3.45	0.69	3.10	1.03	0.34
cerebellum, newborn, donor10223	10357-105E6	29.06	29.06	3.32	4.98	2.49	0.83	0.83	0.00	0.83
cerebral meninges, adult	10188-103D8	57.74	48.92	11.09	10.59	5.80	0.76	2.77	3.28	1.26
cerebrospinal fluid, donor2	10294-104G6	30.70	48.24	5.12	10.23	3.65	3.65	1.46	0.73	1.46
cervical cancer cell line:D98-AH2	10552-107I3	89.29	24.30	21.57	3.45	21.42	4.46	1.44	0.86	0.58
cervical cancer cell line:ME-180	10553-107I4	71.92	30.66	24.03	8.78	10.61	1.99	2.65	1.49	0.99
cervix, adult, pool1	10013-101C4	95.44	28.87	12.39	9.45	5.67	1.57	5.14	1.26	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	49.88	17.14	24.11	6.55	14.91	1.95	2.09	0.84	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	31.35	11.76	0.00	19.59	1.31	0.00	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	108.37	42.63	27.46	23.12	9.57	3.85	5.72	2.11	1.37
choriocarcinoma cell line:SCH	10785-110H2	178.53	58.77	40.17	89.95	12.20	18.48	6.90	2.22	3.45
choriocarcinoma cell line:T3M-3	10618-108G6	73.76	56.92	19.45	20.87	12.33	4.03	2.13	4.03	0.24
chorionic membrane cells, donor1	12238-129G6	65.25	17.10	15.96	5.70	6.84	3.13	1.99	1.42	0.28
chorionic membrane cells, donor2	12239-129G7	66.72	17.80	21.97	5.27	8.35	1.99	2.09	0.40	0.60
chorionic membrane cells, donor3	12240-129G8	64.84	17.03	5.49	6.04	12.64	2.75	3.30	1.10	3.30
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	53.52	30.29	14.14	8.08	5.05	9.09	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	86.83	19.59	22.48	6.53	6.34	3.84	1.73	1.15	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	84.05	27.45	20.70	4.22	5.70	2.75	1.06	1.06	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	91.16	13.35	10.27	4.11	7.19	1.80	1.28	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	103.28	19.83	12.82	3.14	6.77	1.45	3.39	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	112.19	22.19	16.29	4.89	6.72	1.43	1.83	1.43	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	97.46	27.09	17.08	2.94	7.66	4.42	1.77	1.18	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	129.53	32.58	25.54	9.38	8.86	0.78	7.04	2.35	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	130.06	15.09	24.69	8.69	6.17	11.89	3.20	0.91	3.20
clear cell carcinoma cell line:TEN	10636-108I6	86.41	26.03	23.94	11.80	14.40	4.51	1.39	0.87	0.87
colon carcinoma cell line:CACO-2	10513-107D9	105.62	19.95	41.18	25.08	12.08	5.31	2.38	0.55	0.00
colon carcinoma cell line:COLO-320	10420-106C6	150.51	52.45	15.20	23.18	20.52	1.90	9.88	1.90	0.76
colon, adult, donor1	10082-102B1	58.31	11.90	8.33	8.33	5.95	2.38	2.38	2.38	0.00
colon, adult, pool1	10014-101C5	103.52	28.91	13.51	12.22	5.52	1.29	4.00	2.00	0.71
colon, fetal, donor1	10070-101I7	82.81	13.60	12.36	5.56	4.33	4.33	3.71	0.00	1.85
common myeloid progenitor CMP, donor1	12130-128D6	151.26	178.76	27.50	32.08	9.17	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	50.07	0.00	0.00	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	159.35	46.74	46.32	11.90	11.90	7.22	5.10	1.27	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	123.91	23.55	28.83	6.49	5.89	5.28	3.17	0.91	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	123.95	23.27	27.78	8.32	6.91	5.08	2.96	0.99	0.99
corpus callosum, adult, pool1	10042-101F6	75.96	29.74	13.49	14.15	4.31	0.44	4.75	1.66	0.22
cruciate ligament, donor2	10295-104G7	47.82	29.99	11.35	1.62	4.86	4.05	3.24	2.43	0.81
diaphragm, fetal, donor1	10069-101I6	69.82	24.88	4.82	13.64	5.62	6.42	3.21	0.00	1.61
diencephalon, adult	10193-103E4	37.20	28.80	6.00	5.76	4.32	1.44	2.40	1.68	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	81.51	21.58	16.99	16.07	5.74	6.66	1.38	0.69	4.36
ductal cell carcinoma cell line:KLM-1	10438-106E6	133.86	74.88	30.00	6.67	11.28	0.51	2.05	1.54	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	89.55	11.55	16.85	7.22	8.91	5.54	0.72	0.48	1.93
ductus deferens, adult	10196-103E7	48.34	22.43	6.48	5.98	1.99	1.50	1.99	2.49	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	51.85	15.84	11.52	2.88	4.32	7.20	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	71.36	22.81	8.83	5.15	1.47	1.47	0.74	0.74	3.68
dura mater, adult, donor1	10041-101F5	100.76	42.62	20.65	13.13	13.63	0.91	3.96	2.31	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	44.64	23.76	16.21	6.22	3.33	2.89	0.89	0.44	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	46.57	18.34	9.17	7.31	4.01	3.30	1.15	0.29	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	36.38	85.09	8.02	3.70	9.25	1.85	0.62	3.70	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	55.09	30.57	11.50	3.33	9.08	5.45	0.61	1.51	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	51.56	62.68	15.13	2.16	7.10	2.47	0.62	4.32	1.54
embryonic pancreas cell line:2C6	10603-108E9	55.17	84.06	11.82	1.31	7.88	1.31	0.00	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	116.65	63.35	31.17	5.70	30.50	6.37	4.36	1.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	140.46	36.61	52.56	8.52	23.20	9.61	5.44	1.99	3.08
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	81.21	16.08	20.74	4.50	4.34	3.38	0.96	1.13	1.93
epidermoid carcinoma cell line:A431	10426-106D3	138.39	31.46	29.68	8.56	10.78	1.89	2.45	1.11	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	100.31	24.64	40.14	14.41	15.62	3.85	1.65	0.66	0.88
epididymis, adult	10197-103E8	64.89	34.75	12.56	11.09	6.28	3.14	2.93	2.30	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	174.93	23.60	82.67	20.05	37.97	9.23	4.79	1.77	3.55
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	113.65	19.27	75.50	11.40	18.48	1.97	1.97	0.39	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	70.64	27.91	16.12	5.24	11.14	6.81	1.44	0.92	1.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	76.77	25.20	21.26	7.78	13.39	7.48	1.67	0.79	1.38
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	71.81	26.44	22.41	6.61	11.65	7.06	1.23	1.23	1.79
esophagus, adult, pool1	10015-101C6	100.98	21.55	17.41	6.58	7.43	1.06	2.65	0.85	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	176.71	27.80	31.43	9.89	23.29	2.25	8.14	2.00	0.88
eye - muscle inferior rectus, donor1	10272-104E2	60.36	60.36	12.07	0.00	2.41	2.41	2.41	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	33.67	73.65	4.21	4.21	0.00	6.31	0.00	2.10	2.10
eye - muscle medial, donor2	10299-104H2	29.76	68.46	8.93	4.46	0.00	0.00	0.00	2.98	1.49
eye - muscle superior, donor2	10297-104G9	47.01	33.25	6.88	4.59	2.29	2.29	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	36.43	65.58	2.91	1.46	4.37	5.83	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	60.25	16.78	8.64	9.92	4.32	1.78	1.53	1.27	2.54
fibrosarcoma cell line:HT-1080	10758-110E2	98.60	21.41	29.88	5.90	17.57	8.46	1.67	1.28	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	78.82	37.75	23.03	9.50	9.73	9.26	3.09	2.85	0.71
frontal lobe, adult, pool1	10040-101F4	38.56	41.66	6.10	6.29	3.75	0.19	4.22	3.47	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	165.44	39.33	49.54	12.01	14.11	10.51	3.60	1.50	3.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	84.85	17.01	30.63	4.02	15.45	1.10	1.74	0.73	0.46
gall bladder, adult	10198-103E9	68.81	21.25	12.07	9.90	4.59	0.72	2.41	1.21	1.45
gamma delta positive T cells, donor1	11937-126A2	93.95	44.02	17.18	15.03	3.22	4.83	6.44	1.07	1.61
gamma delta positive T cells, donor2	11938-126A3	97.48	46.31	19.05	14.57	6.72	8.59	2.99	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	49.64	17.74	11.62	6.34	4.86	4.01	1.48	0.21	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	88.39	62.67	26.69	9.28	16.05	3.29	3.48	3.67	1.74
gastric cancer cell line:AZ521	10549-107H9	75.58	23.45	18.36	9.84	14.76	3.12	4.10	1.31	0.33
gastric cancer cell line:GSS	10560-108A2	204.10	20.13	17.39	8.24	5.49	0.92	8.24	0.00	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	85.67	42.72	19.88	23.76	8.22	5.94	3.88	0.69	5.03
giant cell carcinoma cell line:LU65	10487-107B1	73.66	26.62	11.82	3.67	8.38	3.79	1.03	1.03	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	99.37	35.83	15.12	15.82	7.56	1.96	5.60	1.54	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	74.33	38.16	19.45	4.74	13.47	1.50	2.49	1.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	94.79	14.78	41.27	8.13	14.36	3.27	2.01	1.37	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	85.95	16.15	41.85	5.76	20.93	2.81	2.95	0.56	0.56
glioblastoma cell line:T98G	10485-107A8	45.92	8.06	9.60	1.66	8.17	1.66	0.88	0.55	0.22
glioma cell line:GI-1	10413-106B8	43.35	12.01	10.84	6.74	11.72	1.76	2.34	1.17	0.29
globus pallidus - adult, donor10196	10175-103C4	63.42	26.24	11.66	5.10	5.10	1.46	0.73	5.83	0.00
globus pallidus, adult, donor10252	10161-103A8	101.30	44.18	20.02	13.91	7.08	2.93	2.69	2.44	1.71
globus pallidus, adult, donor10258	10367-105F7	28.75	21.91	6.85	4.11	1.37	1.37	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	66.61	20.25	11.72	8.53	0.53	1.60	1.07	2.66	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	173.75	242.27	44.05	34.26	19.58	0.00	4.89	12.24	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	54.64	21.86	0.00	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00	5.23	5.23	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	53.76	14.72	14.40	5.44	8.32	2.56	1.28	0.96	0.96
hIPS +CCl2, biol_rep1	14383-156B9	82.64	20.66	11.94	12.40	1.84	0.92	0.46	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	80.02	14.18	14.63	11.43	4.12	1.37	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	91.46	14.17	14.81	15.46	4.51	1.93	0.00	1.29	0.64
hIPS, biol_rep1	14380-156B6	64.68	17.25	10.06	8.62	0.00	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	62.41	12.35	8.23	14.40	0.69	0.69	0.00	1.37	0.00
hIPS, biol_rep3	14382-156B8	46.35	38.62	2.21	7.72	1.10	2.21	1.10	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	94.54	15.23	19.25	6.90	8.33	7.76	2.59	1.15	1.44
heart - mitral valve, adult	10205-103F7	79.82	34.68	17.94	5.08	5.38	2.69	2.09	1.49	0.90
heart - pulmonic valve, adult	10206-103F8	81.84	45.24	16.47	7.06	6.80	3.14	3.14	2.35	0.78
heart - tricuspid valve, adult	10207-103F9	214.82	59.12	50.79	16.65	7.49	3.33	3.33	5.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	65.71	25.71	18.98	6.94	7.35	3.88	1.84	1.43	2.04
heart, adult, diseased, donor1	10051-101G6	57.49	41.31	9.37	4.68	5.96	2.55	0.43	1.70	1.28
heart, adult, pool1	10016-101C7	114.30	76.81	23.46	11.96	12.88	0.69	5.29	5.52	0.23
heart, fetal, pool1	10046-101G1	88.72	46.10	18.79	13.66	8.11	0.51	4.31	3.18	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	64.17	19.44	22.83	2.16	12.96	2.16	1.23	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	58.27	83.24	16.65	1.19	10.70	0.00	1.19	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	85.74	32.82	24.09	13.92	13.92	4.64	2.43	1.10	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	84.35	30.59	26.22	16.02	11.41	5.22	2.31	1.58	2.91
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	83.07	34.36	25.06	17.08	12.53	4.35	2.73	1.21	1.82
hepatoma cell line:Li-7	10484-107A7	128.34	33.59	65.06	8.01	17.02	7.34	1.00	1.00	1.45
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	166.43	34.47	52.66	34.37	29.15	7.24	4.82	2.21	3.12
hippocampus - adult, donor10196	10169-103B7	38.80	41.64	4.73	4.73	3.79	1.89	2.84	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	60.21	51.23	8.98	14.70	5.51	2.65	4.29	1.43	1.02
hippocampus, adult, donor10258	10374-105G5	39.84	40.33	3.98	4.98	0.00	0.00	0.50	2.99	0.50
hippocampus, newborn, donor10223	10363-105F3	31.72	28.55	10.57	1.41	5.64	1.76	0.00	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	121.46	14.04	18.92	21.36	6.71	7.32	2.44	1.22	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	95.43	15.12	8.64	11.19	4.52	5.50	1.77	0.59	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	102.83	13.20	10.66	18.79	2.29	7.11	4.06	0.51	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	71.61	23.12	16.92	18.04	3.38	5.07	3.95	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	76.69	18.59	11.88	16.53	5.68	3.36	5.42	0.52	3.36
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	85.79	28.47	18.98	27.71	4.56	4.93	7.59	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	58.68	16.06	12.85	16.93	6.71	3.80	4.38	0.58	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	75.40	18.10	13.79	12.71	5.60	3.66	2.15	0.22	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	70.07	16.27	19.19	11.26	5.00	0.83	2.09	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	40.25	27.23	13.26	13.97	7.81	5.21	3.32	0.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	56.89	21.70	12.38	10.61	9.16	5.14	3.05	0.32	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	53.86	22.89	10.10	8.75	7.41	2.69	2.02	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	76.21	11.74	7.51	11.27	3.29	4.69	2.97	0.31	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	63.87	7.86	4.91	13.76	1.47	3.93	1.47	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	104.73	13.09	6.11	21.82	3.49	5.24	3.49	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	115.12	20.81	23.10	22.15	9.35	7.06	4.77	0.57	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	107.27	22.68	24.42	17.88	10.90	6.54	3.05	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	97.45	27.99	21.99	22.49	10.00	5.00	2.50	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	49.17	12.43	5.65	10.93	3.96	2.45	2.83	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	54.57	14.55	4.55	5.46	7.73	5.00	4.55	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	56.38	15.35	8.14	13.47	1.88	7.20	3.13	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	39.19	17.64	9.14	8.17	6.70	3.76	1.63	0.16	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	43.26	19.74	11.03	8.42	6.39	2.90	1.16	0.87	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	46.03	22.12	12.55	12.26	5.38	4.78	2.09	1.20	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	99.76	13.12	8.13	10.72	4.06	7.39	3.14	0.74	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	77.31	11.41	10.27	11.41	4.56	5.14	1.71	0.86	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	97.59	18.78	20.42	13.88	7.35	4.49	4.90	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	90.84	18.31	23.59	14.44	7.75	4.93	2.82	1.06	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	94.71	18.37	26.29	18.05	5.70	4.43	4.12	0.32	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	101.38	19.07	36.01	18.16	9.08	6.36	4.54	0.30	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	44.47	16.03	6.21	6.72	5.69	2.59	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	44.50	12.62	3.32	5.98	5.31	1.99	3.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	41.81	16.93	8.21	5.90	4.62	3.08	2.05	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	52.66	19.43	14.06	8.95	9.20	3.83	1.79	0.26	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	44.68	15.90	11.36	6.82	4.54	3.03	3.03	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	64.86	20.84	17.47	6.39	8.07	6.39	1.01	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	84.53	13.52	13.52	10.14	5.31	3.14	1.45	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	91.36	24.07	8.47	13.82	3.57	5.79	2.23	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	82.44	11.22	13.66	11.71	4.39	4.39	1.95	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	95.66	20.17	18.95	21.09	7.64	2.75	2.75	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	292.79	110.61	71.57	107.36	16.27	22.77	26.03	0.00	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	103.92	20.85	28.79	25.48	6.29	5.96	2.65	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	57.47	19.16	6.02	7.11	3.83	1.64	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	48.49	15.56	7.96	11.94	4.70	1.09	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	48.40	14.59	8.90	10.32	4.63	3.91	3.56	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	64.44	16.71	7.16	7.16	0.00	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	55.80	26.81	13.95	14.76	9.89	2.17	3.11	0.81	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	47.41	21.82	17.51	7.81	8.35	6.47	2.42	0.81	0.00
immature langerhans cells, donor1	11904-125F5	96.13	61.02	22.52	7.99	16.95	4.60	1.21	2.42	0.73
immature langerhans cells, donor2	11905-125F6	59.41	25.35	26.93	5.54	4.75	4.75	0.79	3.96	1.58
insula, adult, pool1	10039-101F3	41.92	49.87	6.06	6.91	3.88	0.19	2.84	1.70	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	69.58	10.08	8.13	4.55	6.83	3.25	0.33	0.65	0.33
kidney, adult, pool1	10017-101C8	68.69	32.44	17.52	7.31	4.71	1.00	3.30	1.50	0.30
kidney, fetal, pool1	10045-101F9	66.77	21.93	12.87	9.27	5.38	0.50	2.26	0.85	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	72.71	43.74	21.45	3.69	20.88	2.98	1.56	1.85	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.71	10.78	4.70	3.73	8.57	2.35	0.55	0.28	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	74.13	51.38	25.51	9.73	11.38	2.94	2.20	1.65	0.18
left atrium, adult, donor1	10079-102A7	58.30	36.51	9.81	13.08	7.08	2.72	0.54	0.00	1.63
left ventricle, adult, donor1	10078-102A6	74.33	31.35	18.20	5.56	13.15	2.53	1.01	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	72.23	12.31	24.62	3.01	11.49	3.83	0.55	1.09	0.00
leiomyoma cell line:10964C	10569-108B2	36.64	5.39	9.70	2.16	5.75	2.16	0.36	0.00	1.44
leiomyoma cell line:15242A	10570-108B3	39.67	11.96	17.93	1.09	7.07	3.80	1.09	0.00	0.00
leiomyoma cell line:15425	10571-108B4	46.38	11.66	13.11	2.91	5.10	3.40	0.49	0.00	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	25.40	6.35	0.00	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	20.91	7.32	1.05	3.14	3.14	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	126.91	31.99	38.96	8.26	9.56	5.08	1.30	1.18	1.65
liposarcoma cell line:KMLS-1	10782-110G8	25.31	5.78	10.62	2.19	3.44	0.94	0.00	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	46.79	22.66	19.13	3.78	10.84	2.07	0.85	1.34	0.12
liver, adult, pool1	10018-101C9	78.92	32.41	26.74	8.43	8.27	1.78	2.59	1.62	0.16
liver, fetal, pool1	10086-102B5	36.69	14.11	10.35	4.70	6.58	1.88	1.88	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	81.37	48.27	9.62	11.08	3.50	2.04	4.37	2.19	0.87
locus coeruleus, adult, donor10252	10165-103B3	61.82	35.25	12.18	12.73	4.43	3.88	2.58	1.29	0.92
locus coeruleus, adult, donor10258	10375-105G6	27.65	13.26	5.64	5.36	1.97	1.97	1.13	1.13	0.28
locus coeruleus, newborn, donor10223	10362-105F2	93.80	26.50	29.44	7.99	3.36	2.10	3.79	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	50.38	17.44	14.53	4.98	12.32	1.52	3.18	0.42	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	45.50	51.02	8.96	4.14	13.79	0.00	2.07	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	97.02	32.29	26.89	4.22	15.16	1.98	2.64	0.79	0.79
lung, adult, pool1	10019-101D1	146.36	23.86	19.14	12.17	7.68	0.83	4.02	1.65	0.59
lung, fetal, donor1	10068-101I5	128.15	40.53	14.84	9.99	4.00	0.00	2.85	0.29	0.57
lung, right lower lobe, adult, donor1	10075-102A3	72.40	18.79	18.33	7.33	8.25	1.37	2.29	0.92	0.46
lymph node, adult, donor1	10077-102A5	95.62	31.72	15.62	14.67	12.31	5.68	4.26	0.95	2.84
lymphangiectasia cell line:DS-1	10727-110A7	170.08	29.81	42.30	28.49	13.15	11.18	2.85	1.10	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	130.70	35.77	36.22	39.54	10.26	6.79	3.47	1.66	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	83.25	93.44	16.99	8.49	11.04	3.40	1.70	4.25	0.00
mature adipocyte, donor1	12231-129F8	146.07	54.61	57.72	16.43	22.20	10.66	5.77	2.22	0.44
mature adipocyte, donor2	12232-129F9	150.46	44.41	54.99	19.92	15.98	4.77	5.60	1.04	0.42
mature adipocyte, donor3	12233-129G1	129.91	39.59	34.61	18.25	14.22	3.32	4.03	3.79	0.24
mature adipocyte, donor4	12234-129G2	164.77	42.90	32.90	15.00	15.79	2.90	3.95	2.11	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	102.45	116.27	26.69	13.10	13.82	0.95	7.86	5.72	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	50.76	32.71	4.51	5.64	3.38	4.51	2.26	2.26	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	64.37	51.49	9.01	10.85	3.13	1.66	3.68	2.02	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	23.83	45.11	4.77	6.35	3.81	2.54	0.32	1.59	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	57.15	46.49	8.53	5.54	5.54	0.85	1.28	1.71	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	53.49	59.06	6.92	7.43	3.21	1.18	3.04	3.04	7.59
medial temporal gyrus, adult, donor10252	10156-103A3	59.00	64.52	8.91	8.28	3.18	1.27	1.70	2.12	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	30.82	3.85	9.63	0.00	3.85	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	143.54	28.71	43.06	14.35	0.00	14.35	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	31.23	35.53	3.95	3.95	1.44	1.79	1.44	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	62.30	31.15	12.33	6.49	4.54	3.24	1.95	0.00	1.30
medulla oblongata, adult, donor10252	10155-103A2	73.53	40.25	13.62	14.86	4.18	1.70	3.56	1.55	1.24
medulla oblongata, adult, pool1	10038-101F2	61.22	35.59	8.57	13.31	3.92	0.57	4.98	2.20	0.41
medulla oblongata, newborn, donor10223	10361-105F1	52.77	20.48	20.14	5.90	3.82	1.39	2.43	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	131.74	62.88	15.72	30.78	22.14	4.43	7.09	1.77	2.66
medulloblastoma cell line:ONS-76	10759-110E3	85.47	20.91	27.02	4.52	10.39	1.59	0.73	1.22	1.35
melanoma cell line:COLO 679	10514-107E1	51.46	34.07	19.41	3.31	16.10	2.30	1.87	0.14	0.14
melanoma cell line:G-361	10465-106H6	38.82	25.25	13.30	1.90	18.19	2.44	0.27	1.36	1.36
meningioma cell line:HKBMM	10691-109F7	62.77	23.34	17.19	3.08	7.60	4.88	1.27	1.09	2.53
merkel cell carcinoma cell line:MKL-1	10843-111E6	68.73	48.46	6.17	11.46	1.76	4.41	2.64	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	46.66	32.14	9.85	6.48	0.78	3.11	2.07	0.78	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	45.26	8.75	7.21	4.14	5.68	1.23	1.07	0.46	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	37.81	8.54	6.73	4.00	9.27	0.55	1.27	0.36	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	36.86	6.63	4.97	6.21	3.73	0.83	0.41	2.07	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	29.50	9.55	6.46	4.35	6.60	1.55	1.26	0.42	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	38.32	10.98	5.01	5.39	8.09	0.77	1.35	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	45.12	9.72	10.41	3.47	6.94	4.16	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	33.81	9.44	5.49	4.29	6.35	0.69	2.23	0.86	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	46.35	7.82	13.11	4.14	7.48	1.73	1.96	0.12	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	36.34	8.09	6.37	3.32	4.38	0.93	1.06	0.53	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	47.53	9.72	8.78	4.32	6.21	2.43	1.62	0.95	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	55.91	11.52	9.10	7.26	5.12	1.85	2.99	0.57	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	61.26	14.49	15.15	5.93	9.88	4.28	1.98	0.99	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	45.39	12.45	10.52	4.01	7.89	0.97	1.94	0.55	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	52.01	12.92	6.98	4.54	1.75	4.89	1.75	1.05	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	34.91	9.39	7.15	3.27	5.72	0.20	1.22	0.20	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	44.93	13.66	10.78	2.88	7.91	8.99	0.72	1.08	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	43.66	7.45	7.03	3.41	6.41	0.93	2.07	0.41	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	47.42	11.63	23.03	2.74	6.84	6.16	1.14	0.00	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	51.19	18.04	13.01	3.78	12.59	0.00	1.68	1.26	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	34.82	12.10	5.68	4.18	4.93	0.75	2.54	0.75	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	42.89	15.58	6.83	8.32	7.00	0.79	3.50	0.70	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	59.27	16.94	7.73	7.36	5.52	1.47	1.10	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	48.36	12.30	11.45	5.44	6.58	4.86	1.14	0.00	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	109.46	13.05	51.36	15.16	10.53	15.16	3.79	0.00	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	41.56	9.13	9.13	0.91	5.02	1.83	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	43.99	5.88	14.07	4.86	6.65	4.35	1.28	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	53.40	9.16	9.16	4.45	6.81	4.19	1.05	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	49.60	6.16	13.86	5.55	4.01	4.31	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	40.95	9.88	7.77	2.35	4.71	2.12	2.12	0.00	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	49.75	9.82	7.45	3.05	6.43	3.72	0.68	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	52.66	10.22	5.89	3.93	5.11	4.72	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	58.85	7.41	8.80	3.24	6.95	1.39	1.39	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	57.68	8.36	9.52	4.33	7.21	2.88	0.00	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	49.75	11.38	8.25	4.69	4.91	2.23	1.34	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	46.15	7.45	10.82	5.05	6.73	3.61	0.48	0.48	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	47.67	14.67	11.73	3.67	5.87	1.47	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	34.24	4.70	7.38	3.36	5.71	4.03	0.67	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	51.58	8.60	6.96	3.68	6.55	2.46	0.41	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	43.81	8.16	7.73	3.01	8.16	0.86	0.43	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	51.95	2.73	13.67	0.00	2.73	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	0.00	0.00	5.16	10.33	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	48.39	8.77	11.37	3.57	5.85	10.39	2.60	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	43.65	10.18	14.55	2.91	5.82	7.27	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	55.44	8.00	13.33	4.80	3.73	9.06	1.60	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	58.06	9.81	8.18	1.64	4.09	5.72	1.64	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	49.37	8.16	8.16	3.11	6.22	8.55	0.00	0.39	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	56.67	6.30	6.30	0.00	8.39	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	47.69	8.94	6.95	0.99	9.93	8.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	0.00	14.30	9.53	9.53	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	48.03	7.71	10.67	2.96	6.52	8.30	1.19	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	53.61	6.09	7.31	2.44	4.87	7.31	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	27.05	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	35.47	8.87	6.33	4.43	5.70	8.23	0.63	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	40.70	6.21	6.90	1.38	4.14	5.17	1.72	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	58.03	12.90	0.00	2.15	4.30	8.60	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	11.98	3.99	3.99	3.99	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	61.99	3.44	0.00	0.00	3.44	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	45.23	6.93	4.48	2.04	3.26	2.44	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.93	5.56	3.18	3.97	8.74	3.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	43.04	3.54	4.13	1.18	2.95	2.95	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	46.76	5.92	5.92	2.81	3.12	3.43	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	38.76	9.36	4.01	0.00	5.35	8.02	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	49.67	7.10	8.28	0.00	2.37	0.00	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	74.47	12.84	7.70	0.00	7.70	10.27	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	58.51	9.64	9.64	3.44	4.13	5.51	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	49.98	13.85	13.36	8.91	4.95	6.43	1.98	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	53.83	10.09	11.22	4.49	4.49	7.85	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	50.89	10.81	16.54	7.63	1.91	6.36	1.91	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	62.06	9.27	10.07	7.66	4.03	4.43	0.81	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	61.06	19.63	21.81	4.36	10.90	6.54	4.36	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	54.48	11.40	0.00	3.80	2.53	5.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	95.89	18.21	19.42	8.50	20.03	3.03	4.25	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	103.94	4.52	31.63	13.56	27.11	13.56	4.52	0.00	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	88.13	12.36	14.83	14.00	18.94	13.18	3.29	0.00	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	55.76	7.14	7.14	3.77	3.97	3.97	1.98	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	44.46	6.17	11.03	4.22	4.54	4.87	0.65	0.00	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	47.88	9.17	13.24	2.04	5.09	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.08	24.76	5.42	5.42	4.64	0.77	2.32	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	224.67	32.60	55.28	8.27	34.96	5.20	4.25	2.13	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	139.00	24.79	53.28	6.26	21.78	7.88	1.62	0.46	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	76.92	25.64	12.82	4.27	17.09	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	55.28	9.76	16.85	3.80	10.89	1.23	1.13	0.21	2.47
mesothelioma cell line:Mero-25	10850-111F4	101.90	26.78	39.04	4.99	11.57	4.99	1.13	1.13	3.40
mesothelioma cell line:Mero-41	10851-111F5	144.48	23.71	44.01	6.85	12.71	4.40	2.44	0.73	2.20
mesothelioma cell line:Mero-48a	10852-111F6	65.99	17.27	30.11	3.10	9.74	4.43	0.44	1.33	1.33
mesothelioma cell line:Mero-82	10853-111F7	119.84	22.34	56.50	7.88	16.29	14.19	1.58	0.79	3.42
mesothelioma cell line:Mero-83	10854-111F8	42.73	11.92	14.98	2.21	8.85	3.06	0.17	0.68	1.02
mesothelioma cell line:Mero-84	10855-111F9	108.19	7.84	27.05	7.84	2.27	3.79	2.53	0.51	1.26
mesothelioma cell line:Mero-95	10856-111G1	132.71	11.18	50.93	16.56	13.04	5.38	2.48	0.41	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	88.62	21.87	42.24	4.80	9.77	8.61	1.49	0.50	1.33
mesothelioma cell line:NCI-H226	10846-111E9	47.24	7.78	20.27	1.63	9.23	2.71	1.27	0.00	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	88.49	20.50	26.48	4.10	10.76	3.76	1.88	0.85	1.54
mesothelioma cell line:NCI-H28	10845-111E8	48.35	10.69	9.92	2.80	6.87	4.83	1.27	0.51	0.76
mesothelioma cell line:No36	10857-111G2	66.22	14.03	18.59	2.94	6.52	5.87	0.98	0.98	0.65
mesothelioma cell line:ONE58	10858-111G3	104.59	42.00	31.43	4.34	8.67	6.23	0.81	0.00	2.17
migratory langerhans cells, donor1	11901-125F2	56.43	26.10	9.21	7.68	3.84	1.54	1.15	0.38	0.58
migratory langerhans cells, donor2	11902-125F3	65.94	32.24	13.31	6.59	3.30	0.98	1.71	1.22	0.37
migratory langerhans cells, donor3	11903-125F4	57.61	32.13	8.97	11.13	3.59	0.90	1.44	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	105.78	31.02	22.53	7.84	11.10	6.86	2.61	0.98	2.61
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	68.46	16.95	13.78	7.84	7.63	9.96	1.70	1.06	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	86.38	61.74	40.54	3.92	23.50	2.53	0.69	5.07	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	106.56	20.36	32.35	9.13	10.09	7.23	1.90	1.71	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	96.28	32.15	20.70	12.20	17.56	5.91	3.14	0.74	1.29
myeloma cell line:PCM6	10474-106I6	261.51	95.28	77.29	10.28	45.66	42.50	5.14	2.77	3.16
myxofibrosarcoma cell line:MFH-ino	10600-108E6	62.90	20.80	20.80	2.03	8.12	3.04	1.52	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	47.07	14.71	10.79	4.90	8.24	7.65	0.39	0.20	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	100.17	18.27	18.05	5.24	8.47	4.79	2.45	0.67	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	113.25	18.31	23.09	5.88	10.44	3.24	2.06	0.37	0.59
nasal epithelial cells, donor2	12227-129F4	71.21	12.70	20.98	3.31	11.59	2.21	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	67.41	90.41	14.95	17.94	21.63	3.22	4.83	3.45	0.23
neuroblastoma cell line:NB-1	10539-107G8	55.38	51.26	6.74	8.61	3.55	1.31	2.81	1.68	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	25.52	43.44	6.54	10.54	4.85	3.59	2.53	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	95.97	30.56	11.74	20.50	18.08	5.59	3.91	1.68	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	49.82	22.77	5.69	15.89	6.41	3.32	3.32	0.71	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.88	24.87	3.80	5.23	3.64	2.38	2.69	1.27	1.43
neuroectodermal tumor cell line:TASK1	10774-110F9	99.42	39.65	14.29	19.92	15.70	17.91	3.22	3.02	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	56.58	174.84	10.81	9.54	11.44	3.18	0.64	8.90	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	76.39	14.11	29.01	3.19	7.98	3.19	0.80	0.53	0.80
neutrophil PMN, donor1	12133-128D9	223.12	208.25	59.50	14.87	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	39.84	53.12	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	28.41	37.88	18.94	9.47	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	135.63	25.20	15.39	21.31	7.61	2.88	5.92	1.01	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	16.01	10.41	3.20	2.40	3.20	3.20	4.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	78.55	9.94	37.83	7.69	13.47	11.22	2.24	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	95.38	11.30	44.93	7.36	13.14	8.15	1.31	0.26	3.42
nucleus accumbens, adult, pool1	10037-101F1	36.00	36.00	6.66	7.87	3.00	0.19	3.00	1.12	0.28
occipital cortex - adult, donor10196	10172-103C1	41.21	43.27	4.12	10.30	4.12	0.00	2.06	6.18	2.06
occipital cortex, adult, donor10252	10163-103B1	77.02	66.29	11.00	13.95	4.56	2.15	2.15	3.76	1.34
occipital cortex, newborn, donor10223	10355-105E4	31.30	45.86	10.19	3.28	3.64	0.00	1.09	3.28	0.00
occipital lobe, adult, donor1	10076-102A4	38.05	40.93	4.72	10.50	2.62	7.87	2.10	2.10	1.84
occipital lobe, fetal, donor1	10073-102A1	48.92	46.77	9.87	9.87	8.15	5.58	5.15	1.29	0.86
occipital pole, adult, pool1	10036-101E9	28.15	34.61	3.39	6.47	2.37	0.00	2.21	1.26	0.24
olfactory region, adult	10195-103E6	45.47	36.68	5.16	11.85	4.01	1.72	3.25	2.48	0.57
optic nerve, donor1	10277-104E7	44.02	30.02	6.00	2.00	4.00	2.00	2.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	58.89	29.50	16.06	8.20	7.75	2.39	2.85	1.25	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	73.50	19.23	10.99	4.40	4.40	1.65	1.10	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	58.42	25.06	11.85	7.45	7.62	3.05	0.85	0.68	2.71
oral squamous cell carcinoma cell line:SAS	10544-107H4	98.64	36.04	26.34	14.32	12.13	3.81	3.47	1.96	1.73
osteoclastoma cell line:Hs 706.T	10704-109H2	53.50	14.11	17.34	5.00	11.76	3.82	1.18	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	61.67	128.94	14.95	4.67	16.82	0.93	1.87	3.74	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	50.47	11.45	7.85	4.67	1.91	2.97	1.06	0.42	0.00
ovary, adult, pool1	10020-101D2	87.00	32.41	13.36	14.59	7.42	1.14	4.63	1.57	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	64.71	10.27	35.01	4.95	14.30	3.12	0.37	0.55	0.18
pancreas, adult, donor1	10049-101G4	79.01	26.34	12.23	6.58	9.41	6.58	4.70	1.88	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	65.13	85.26	22.64	13.70	11.18	6.71	1.40	3.07	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	66.27	38.84	22.49	4.26	11.58	5.79	0.68	0.85	4.60
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	88.92	26.49	18.88	8.44	4.64	1.49	2.48	0.66	0.83
paracentral gyrus, adult, pool1	10035-101E8	39.35	37.07	6.32	10.25	3.29	0.18	3.84	2.01	0.37
parietal cortex, adult, donor10258	10373-105G4	24.22	27.89	3.67	8.07	0.00	1.47	0.73	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	47.02	47.96	9.40	2.82	0.00	0.94	2.82	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	47.32	59.29	5.99	9.12	2.85	2.00	1.71	2.57	1.71
parietal lobe, adult, pool1	10034-101E7	45.73	43.44	6.17	8.46	2.56	0.44	4.23	2.03	0.26
parietal lobe, fetal, donor1	10072-101I9	68.86	65.95	8.73	8.73	6.79	4.85	1.94	0.97	1.94
parietal lobe, newborn, donor10223	10356-105E5	48.23	41.50	7.48	2.62	1.87	1.50	1.87	1.87	0.37
parotid gland, adult	10199-103F1	63.52	37.00	16.65	12.95	6.78	1.23	2.47	3.08	1.23
penis, adult	10200-103F2	70.90	26.86	6.45	9.67	3.22	1.61	2.69	1.07	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	40.53	21.20	2.60	5.76	5.76	1.67	1.86	0.74	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	90.19	37.88	21.85	12.24	8.60	6.70	3.79	1.89	0.73
pineal gland - adult, donor10196	10179-103C8	54.18	52.25	11.61	2.58	3.87	0.65	0.00	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	54.48	56.85	10.66	9.48	5.92	1.18	0.59	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	52.67	48.28	5.02	5.02	2.51	0.00	3.76	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	81.96	55.65	18.21	15.18	5.06	1.01	4.05	3.04	5.06
pituitary gland, adult, donor10252	10162-103A9	99.02	75.05	17.20	23.97	4.69	2.08	5.21	5.21	1.56
pituitary gland, adult, donor10258	10378-105G9	93.64	40.86	11.92	13.62	8.51	3.40	5.11	3.40	0.85
placenta, adult, pool1	10021-101D3	73.64	26.66	11.50	6.02	3.98	0.65	2.37	0.65	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	94.95	28.74	15.89	15.36	7.68	4.50	2.12	1.06	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	69.10	13.54	11.05	5.45	7.16	2.33	1.09	0.93	0.47
pons, adult, pool1	10033-101E6	38.47	30.98	5.34	9.73	2.58	0.69	3.10	1.81	0.43
postcentral gyrus, adult, pool1	10032-101E5	28.68	37.75	4.27	6.10	2.35	0.52	3.31	1.92	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	158.95	225.87	27.19	12.55	4.18	0.00	10.46	6.27	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	22.03	0.00	0.00	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	93.89	11.74	11.74	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	83.76	8.59	27.97	9.03	7.87	4.52	2.62	0.58	1.31
prostate cancer cell line:PC-3	10439-106E7	43.38	21.96	16.88	3.09	7.44	2.36	0.54	0.18	0.73
prostate, adult, pool1	10022-101D4	78.18	24.12	10.16	7.80	5.62	0.73	2.90	1.36	0.45
putamen, adult, donor10196	10176-103C5	39.19	38.71	5.43	4.01	4.25	2.83	2.12	1.65	1.65
putamen, adult, donor10252	10152-102I8	50.98	37.25	15.69	11.76	1.96	0.00	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	54.64	25.13	3.28	19.67	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	28.75	31.41	4.83	7.01	4.11	0.72	2.17	1.69	0.48
putamen, newborn, donor10223	10365-105F5	59.22	17.24	21.74	6.00	5.25	3.75	3.00	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	146.34	61.68	24.44	12.22	20.37	2.62	4.95	2.33	0.00
rectum, fetal, donor1	10067-101I4	68.16	25.04	5.56	4.17	13.91	2.78	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	93.07	8.48	27.35	2.12	7.63	2.97	0.64	0.21	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	105.21	2.07	4.14	1.66	2.07	8.70	0.83	0.00	0.41
retina, adult, pool1	10030-101E3	59.14	28.03	13.22	5.67	6.86	0.30	3.38	1.69	0.40
retinoblastoma cell line:Y79	10475-106I7	52.22	20.78	4.42	13.51	11.43	5.20	1.56	0.52	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	76.35	10.33	11.19	4.43	2.95	1.72	0.98	0.74	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	165.63	63.83	30.37	9.28	28.68	1.97	5.34	1.69	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	53.05	33.35	22.74	1.52	18.95	1.52	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	55.68	12.14	8.90	3.88	13.27	1.46	1.78	0.16	0.81
salivary acinar cells, donor2	11772-123I8	50.53	10.88	5.37	2.89	7.57	1.10	0.41	0.14	0.69
salivary acinar cells, donor3	11773-123I9	70.18	47.67	15.89	4.63	9.93	0.66	1.99	1.32	0.66
salivary gland, adult, pool1	10093-102C3	41.75	25.17	4.00	9.15	2.29	0.00	3.43	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	106.91	61.97	35.07	12.23	17.45	3.88	5.48	2.45	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	91.22	51.37	26.80	9.76	21.51	5.29	3.53	2.59	1.06
seminal vesicle, adult	10201-103F3	47.62	32.27	3.70	2.12	0.00	1.59	0.53	0.53	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	100.81	16.03	21.86	9.96	3.16	7.53	1.21	0.97	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	54.10	24.16	11.83	10.57	4.03	2.77	1.76	0.50	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	71.25	20.07	14.05	7.02	2.01	4.01	2.01	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	109.61	11.15	38.68	11.28	13.30	7.66	3.09	0.13	1.48
signet ring carcinoma cell line:Kato III	10436-106E4	49.07	41.34	16.47	8.62	5.75	3.54	2.98	1.22	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	100.90	29.29	26.97	5.55	17.42	1.16	1.16	0.90	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	80.86	152.51	29.79	12.77	10.64	5.67	0.00	6.38	0.00
skeletal muscle, adult, pool1	10023-101D5	206.29	145.24	40.66	72.92	36.22	3.12	21.47	7.20	1.44
skeletal muscle, fetal, donor1	10066-101I3	55.28	20.10	11.06	14.07	13.07	7.04	7.04	1.01	1.01
skin, adult, donor1	10074-102A2	74.64	6.79	6.79	0.00	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	50.50	25.25	18.31	9.47	6.31	6.31	1.26	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	36.02	36.02	5.00	15.34	2.00	1.67	1.67	2.00	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	48.23	36.56	9.77	6.30	6.93	3.47	1.58	0.63	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	72.09	10.02	4.43	6.17	1.93	5.40	2.89	0.96	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	109.45	73.18	19.12	17.47	12.03	4.78	6.43	1.81	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	161.81	53.24	7.88	44.56	14.15	6.92	7.40	1.61	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	161.69	74.96	70.17	17.43	18.74	8.06	3.70	2.40	2.40
small intestine, adult, pool1	10024-101D6	90.18	31.53	17.68	8.24	5.02	1.31	3.46	1.07	0.84
small intestine, fetal, donor1	10064-101I1	62.65	17.69	10.07	5.65	6.14	3.93	2.46	0.98	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	63.60	17.44	18.46	4.62	8.21	4.10	1.03	0.00	2.56
smooth muscle, adult, pool1	10048-101G3	80.64	32.31	15.51	5.69	7.24	1.55	1.81	2.84	1.55
somatostatinoma cell line:QGP-1	10781-110G7	80.14	47.44	33.77	1.61	34.04	2.95	0.54	1.61	0.00
spinal cord - adult, donor10196	10181-103D1	71.57	34.64	10.09	10.32	4.82	1.84	3.44	2.06	1.84
spinal cord, adult, donor10252	10159-103A6	100.54	35.48	9.86	17.35	6.31	1.18	2.76	2.37	0.39
spinal cord, adult, donor10258	10369-105F9	55.34	22.14	6.92	8.99	1.38	0.00	0.00	2.77	0.00
spinal cord, fetal, donor1	10056-101H2	59.76	32.93	16.47	12.20	4.88	3.05	1.22	1.83	1.22
spinal cord, newborn, donor10223	10359-105E8	68.42	29.39	15.15	8.27	3.21	0.46	1.38	0.92	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	68.11	18.22	33.90	1.79	13.89	3.58	0.75	0.75	0.00
spleen, adult, pool1	10025-101D7	152.98	46.70	30.73	23.24	8.04	2.64	6.61	2.09	0.99
spleen, fetal, pool1	10044-101F8	91.77	24.15	20.90	10.49	6.83	0.48	2.78	1.11	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	111.48	21.53	29.92	24.64	11.28	3.00	2.90	0.21	2.28
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	102.34	32.47	20.70	6.27	8.73	3.99	3.04	1.90	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	91.91	23.41	30.40	4.89	8.74	3.49	2.45	0.35	3.15
squamous cell carcinoma cell line:T3M-5	10616-108G4	79.75	59.81	30.10	5.47	14.07	1.95	0.78	1.56	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	125.50	74.18	56.39	5.29	23.98	11.37	2.59	2.36	1.91
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	124.96	11.01	23.72	5.93	8.90	3.39	2.12	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	136.65	43.15	38.92	9.73	16.50	1.69	2.12	1.27	0.42
stomach, fetal, donor1	10062-101H8	80.10	71.55	13.88	6.41	8.54	1.07	1.07	5.34	1.07
submaxillary gland, adult	10202-103F4	58.11	34.75	14.81	9.68	3.42	1.71	2.28	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	271.37	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	77.68	29.29	18.28	13.71	3.95	4.98	1.87	1.45	1.25
substantia nigra, adult, donor10258	10371-105G2	42.93	26.38	7.24	6.72	1.03	0.00	0.00	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	56.53	31.80	8.48	7.77	4.95	2.83	0.00	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	52.50	22.93	13.30	3.67	7.34	10.32	2.29	0.92	0.92
temporal lobe, adult, pool1	10031-101E4	31.70	31.62	4.66	5.85	2.71	0.59	2.80	1.95	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	51.28	43.45	7.12	5.70	7.12	4.99	3.56	0.71	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	47.03	38.68	7.03	6.59	7.03	3.96	2.64	1.76	1.76
tenocyte, donor1	11763-123H8	76.45	8.73	16.06	3.14	6.98	4.54	0.35	0.70	2.09
tenocyte, donor2	11765-123I1	60.28	12.21	14.88	4.96	6.49	4.58	1.14	0.00	2.29
tenocyte, donor3	11768-123I4	67.83	8.90	12.23	2.59	5.19	6.30	0.74	0.00	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	160.95	30.08	26.51	23.28	8.33	8.16	2.72	1.02	2.38
teratocarcinoma cell line:NCR-G1	10798-110I6	57.03	13.57	9.40	15.72	6.01	2.47	2.00	0.31	1.08
teratocarcinoma cell line:PA-1	10807-111A6	87.87	20.77	10.07	19.37	4.34	5.42	2.01	0.46	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	205.91	24.75	48.49	34.91	11.43	11.04	5.59	1.40	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	284.39	46.89	31.01	45.38	15.13	5.67	3.78	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	276.47	47.22	22.25	54.09	18.87	1.64	13.09	1.31	5.23
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	149.50	26.06	14.01	21.50	4.89	2.93	3.91	0.00	7.82
testis, adult, pool1	10026-101D8	70.97	28.13	11.81	9.99	7.30	0.43	6.23	1.72	0.97
testis, adult, pool2	10096-102C6	55.48	46.91	8.57	10.83	5.86	3.61	1.80	1.35	3.16
thalamus - adult, donor10196	10168-103B6	61.82	19.87	7.73	8.83	3.31	1.10	1.10	1.10	2.21
thalamus, adult, donor10252	10154-103A1	75.02	38.91	12.66	13.91	3.75	2.66	2.66	2.03	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	58.51	29.25	7.70	12.32	3.08	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	24.70	11.86	2.96	5.43	1.48	0.66	1.32	0.33	0.82
thalamus, newborn, donor10223	10366-105F6	45.45	28.19	13.81	2.88	4.03	2.30	1.15	0.00	1.15
throat, adult	10209-103G2	63.92	24.97	11.48	18.73	6.74	2.00	3.99	1.25	1.75
throat, fetal, donor1	10061-101H7	58.81	28.64	10.36	10.36	8.53	3.35	3.35	1.52	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	69.36	30.41	5.96	7.95	6.16	3.58	3.38	0.79	0.79
thymus, adult, pool1	10027-101D9	141.17	47.62	48.81	67.50	16.60	1.09	9.44	0.99	0.50
thymus, fetal, pool1	10043-101F7	145.78	33.25	51.54	69.72	13.51	1.56	7.38	0.94	1.35
thyroid carcinoma cell line:KHM-5M	10776-110G2	191.46	38.69	53.45	12.37	41.22	9.17	2.39	1.46	2.53
thyroid carcinoma cell line:TCO-1	10783-110G9	97.50	32.13	29.34	11.18	19.14	6.01	2.37	1.12	1.26
thyroid, adult, pool1	10028-101E1	100.50	37.14	22.49	16.42	11.76	1.59	5.69	2.24	0.56
thyroid, fetal, donor1	10060-101H6	102.83	24.78	29.00	8.17	10.55	7.12	2.64	1.58	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	95.47	9.24	0.00	9.24	3.08	3.08	0.00	3.08
tongue, adult	10203-103F5	74.19	31.17	13.49	13.26	7.68	2.33	1.86	2.56	1.86
tongue, fetal, donor1	10059-101H5	87.88	30.35	19.70	13.79	7.09	5.12	4.73	0.79	1.97
tonsil, adult, pool1	10047-101G2	122.21	33.06	25.14	27.55	9.62	0.40	7.61	1.40	0.50
trachea, adult, pool1	10029-101E2	101.35	32.72	19.96	8.92	6.05	1.64	2.62	1.88	0.41
trachea, fetal, donor1	10058-101H4	62.71	21.54	11.93	10.77	4.62	4.23	1.15	1.54	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	67.67	16.30	18.78	1.42	13.82	8.86	1.42	0.71	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	81.76	23.51	18.64	9.02	4.56	1.72	2.53	0.91	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	196.17	48.73	25.85	17.08	17.08	8.93	7.83	1.25	2.04
tridermal teratoma cell line:HGRT	10694-109G1	41.86	41.86	15.22	0.00	11.42	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	65.01	24.13	17.86	6.94	7.11	1.95	2.12	1.61	0.59
umbilical cord, fetal, donor1	10057-101H3	58.42	12.52	14.61	2.09	2.09	2.09	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	75.76	22.86	8.53	10.07	5.12	0.34	4.44	1.02	0.00
uterus, fetal, donor1	10055-101H1	69.62	20.48	10.24	5.12	1.02	5.63	4.10	1.02	0.51
vagina, adult	10204-103F6	107.92	28.43	12.28	10.34	4.52	0.00	2.58	3.88	0.00
vein, adult	10191-103E2	106.75	32.66	23.24	16.22	6.36	1.97	1.32	1.53	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	93.73	16.29	26.97	21.90	17.09	5.61	2.40	1.34	2.14